| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.967 | 0.001 | 0.967 | DNA damaging | 0.898 0.002 DBMET00021 0.911 0.002 DBMET00022 0.243 0.084 DBMET00023 0.957 0.001 DBMET00024 0.446 0.02 DBMET03248 0.905 0.002 DBMET01077 0.792 0.004 DBMET00792 0.907 0.002 DBMET01100 0.913 0.002 DBMET01102 0.885 0.003 DBMET01103 0.691 0.005 DBMET01127 0.257 0.077 DBMET01146 0.633 0.007 DBMET01150 | ||
| 0.935 | 0.001 | 0.978 | Alkylator | 0.862 0.001 DBMET00021 0.825 0.002 DBMET00022 0.232 0.019 DBMET00023 0.97 0.001 DBMET00024 0.36 0.009 DBMET03248 0.809 0.002 DBMET01077 0.775 0.002 DBMET00792 0.978 0.001 DBMET01100 0.846 0.002 DBMET01102 0.821 0.002 DBMET01103 0.162 0.041 DBMET01126 0.78 0.002 DBMET01127 0.159 0.042 DBMET01146 0.742 0.002 DBMET01150 | DBMET01100 | |
| 0.895 | 0.002 | 0.895 | DNA synthesis inhibitor | 0.743 0.004 DBMET00021 0.71 0.004 DBMET00022 0.431 0.018 DBMET00023 0.856 0.002 DBMET00024 0.436 0.018 DBMET03248 0.74 0.004 DBMET01077 0.447 0.017 DBMET00792 0.797 0.003 DBMET01100 0.474 0.015 DBMET01102 0.488 0.014 DBMET01103 0.369 0.026 DBMET01126 0.462 0.016 DBMET01127 0.367 0.027 DBMET01146 0.63 0.006 DBMET01150 | ||
| 0.875 | 0.002 | 0.875 | Immunosuppressant | 0.841 0.003 DBMET00021 0.854 0.003 DBMET00022 0.847 0.003 DBMET00024 0.392 0.067 DBMET03248 0.835 0.003 DBMET01077 0.31 0.109 DBMET00792 0.703 0.005 DBMET01100 0.371 0.076 DBMET01102 0.368 0.077 DBMET01103 0.285 0.125 DBMET01126 0.396 0.065 DBMET01127 0.414 0.058 DBMET01146 0.409 0.059 DBMET01150 | ||
| 0.28 | 0.094 | 0.906 | Immunomodulator | 0.906 0.004 DBMET00021 0.714 0.005 DBMET00022 0.223 0.139 DBMET01100 0.279 0.095 DBMET01146 | DBMET00021 | |
| 0.238 | 0.101 | 0.542 | Immunostimulant | 0.387 0.053 DBMET00021 0.317 0.074 DBMET00022 0.21 0.114 DBMET00023 0.194 0.124 DBMET00024 0.247 0.098 DBMET03248 0.198 0.121 DBMET01077 0.207 0.116 DBMET00792 0.542 0.024 DBMET01100 0.264 0.091 DBMET01102 0.315 0.074 DBMET01103 0.337 0.068 DBMET01126 0.225 0.107 DBMET01127 0.342 0.067 DBMET01146 0.25 0.096 DBMET01150 | DBMET01100 | |
| 0.185 | 0.075 | 0.658 | P-glycoprotein inhibitor | 0.658 0.004 DBMET00021 0.284 0.032 DBMET00022 0.15 0.118 DBMET01077 | DBMET00021 | |
| 0.076 | 0.036 | 0.19 | Bcl2 antagonist | 0.19 0.004 DBMET00021 0.112 0.013 DBMET00022 0.061 0.053 DBMET01100 | DBMET00021 | |
| 0.065 | 0.039 | 0.478 | Carbamoyl phosphate synthetase inhibitor | 0.079 0.029 DBMET00021 0.13 0.014 DBMET00022 0.237 0.006 DBMET00023 0.075 0.031 DBMET00024 0.478 0.003 DBMET03248 0.069 0.035 DBMET01077 0.105 0.019 DBMET00792 0.19 0.008 DBMET01102 0.292 0.004 DBMET01103 0.109 0.018 DBMET01126 0.192 0.008 DBMET01127 0.241 0.006 DBMET01146 0.202 0.007 DBMET01150 | DBMET03248 | |
| 0.073 | 0.092 | 0.575 | Triose-phosphate isomerase inhibitor | 0.09 0.06 DBMET00021 0.129 0.028 DBMET00022 0.546 0.002 DBMET00023 0.575 0.002 DBMET03248 0.08 0.077 DBMET01077 0.224 0.009 DBMET00792 0.219 0.009 DBMET01102 0.344 0.004 DBMET01103 0.402 0.003 DBMET01126 0.253 0.007 DBMET01127 0.466 0.003 DBMET01146 0.263 0.006 DBMET01150 | DBMET03248 | |
| 0.029 | 0.063 | 0.226 | Antimetabolite | 0.056 0.028 DBMET00023 0.062 0.024 DBMET03248 0.126 0.013 DBMET00792 0.076 0.02 DBMET01100 0.189 0.01 DBMET01102 0.226 0.008 DBMET01103 0.051 0.03 DBMET01126 0.112 0.015 DBMET01127 0.128 0.013 DBMET01146 0.089 0.018 DBMET01150 | DBMET01103 | |
| 0.011 | 0.048 | 0.073 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.067 0.006 DBMET00023 0.069 0.006 DBMET03248 0.06 0.007 DBMET00792 0.073 0.005 DBMET01102 0.057 0.008 DBMET01103 0.041 0.012 DBMET01126 0.066 0.006 DBMET01127 0.034 0.015 DBMET01146 0.067 0.006 DBMET01150 | DBMET01102 | |
| 0.011 | 0.06 | 0.034 | Purinergic P2X agonist | 0.034 0.015 DBMET01127 0.034 0.015 DBMET01150 | DBMET01150 | |
| 0.048 | 0.099 | 0.212 | Aminopeptidase I inhibitor | 0.066 0.059 DBMET00021 0.141 0.014 DBMET00023 0.212 0.006 DBMET03248 0.092 0.032 DBMET00792 0.091 0.033 DBMET01100 0.147 0.013 DBMET01102 0.192 0.007 DBMET01103 0.082 0.04 DBMET01126 0.19 0.008 DBMET01127 0.154 0.012 DBMET01146 0.2 0.007 DBMET01150 | DBMET03248 | |
| 0.067 | 0.12 | 0.461 | UDP-glucose 4-epimerase inhibitor | 0.086 0.079 DBMET00021 0.128 0.038 DBMET00022 0.461 0.004 DBMET00023 0.458 0.004 DBMET03248 0.184 0.02 DBMET00792 0.162 0.025 DBMET01102 0.135 0.035 DBMET01103 0.33 0.009 DBMET01126 0.245 0.014 DBMET01127 0.237 0.014 DBMET01146 0.245 0.014 DBMET01150 | DBMET00023 | |
| 0.207 | 0.264 | 0.675 | Apoptosis agonist | 0.545 0.061 DBMET00021 0.465 0.086 DBMET00022 0.249 0.215 DBMET00023 0.49 0.077 DBMET00792 0.303 0.17 DBMET01100 0.584 0.053 DBMET01102 0.544 0.062 DBMET01103 0.675 0.035 DBMET01126 0.54 0.063 DBMET01127 0.586 0.052 DBMET01146 0.54 0.063 DBMET01150 | DBMET01126 | |
| 0.022 | 0.088 | 0.092 | Ribonucleoside-diphosphate reductase inhibitor | 0.061 0.034 DBMET00023 0.068 0.03 DBMET03248 0.045 0.044 DBMET00792 0.074 0.027 DBMET01100 0.071 0.029 DBMET01102 0.086 0.023 DBMET01103 0.05 0.041 DBMET01126 0.061 0.034 DBMET01127 0.092 0.021 DBMET01146 0.067 0.03 DBMET01150 | DBMET01146 | |
| 0.021 | 0.088 | 0.092 | Ribonucleotide reductase inhibitor | 0.062 0.035 DBMET00023 0.071 0.031 DBMET03248 0.046 0.045 DBMET00792 0.075 0.029 DBMET01100 0.073 0.03 DBMET01102 0.088 0.024 DBMET01103 0.049 0.043 DBMET01126 0.066 0.033 DBMET01127 0.092 0.023 DBMET01146 0.072 0.03 DBMET01150 | DBMET01146 | |
| 0.042 | 0.119 | 0.352 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.074 0.056 DBMET00022 0.116 0.03 DBMET00023 0.154 0.017 DBMET03248 0.22 0.008 DBMET00792 0.352 0.004 DBMET01102 0.334 0.004 DBMET01103 0.339 0.004 DBMET01127 0.09 0.044 DBMET01146 0.3 0.004 DBMET01150 | DBMET01102 | |
| 0.046 | 0.125 | 0.509 | Glutamate dehydrogenase inhibitor | 0.074 0.051 DBMET00022 0.212 0.009 DBMET00023 0.279 0.006 DBMET03248 0.078 0.046 DBMET00792 0.072 0.053 DBMET01100 0.107 0.027 DBMET01102 0.215 0.009 DBMET01103 0.175 0.012 DBMET01126 0.161 0.014 DBMET01127 0.509 0.003 DBMET01146 0.161 0.014 DBMET01150 | DBMET01146 | |
| 0.027 | 0.131 | 0.171 | Glucose-6-phosphate isomerase inhibitor | 0.117 0.004 DBMET00023 0.129 0.003 DBMET03248 0.059 0.019 DBMET00792 0.06 0.019 DBMET01102 0.078 0.009 DBMET01103 0.127 0.003 DBMET01126 0.059 0.019 DBMET01127 0.171 0.002 DBMET01146 0.059 0.019 DBMET01150 | DBMET01146 | |
| 0.001 | 0.118 | 0.016 | Mannitol 2-dehydrogenase inhibitor | 0.016 0.003 DBMET03248 | DBMET03248 | |
| 0.053 | 0.182 | 0.257 | NADH dehydrogenase inhibitor | 0.081 0.073 DBMET00022 0.148 0.018 DBMET00023 0.257 0.008 DBMET03248 0.096 0.048 DBMET01102 0.102 0.042 DBMET01103 0.134 0.022 DBMET01126 0.136 0.022 DBMET01127 0.246 0.008 DBMET01146 0.136 0.022 DBMET01150 | DBMET03248 | |
| 0.01 | 0.15 | 0.024 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET00023 0.021 0.007 DBMET03248 0.018 0.014 DBMET01103 0.023 0.005 DBMET01126 0.024 0.004 DBMET01146 | DBMET01146 | |
| 0.018 | 0.169 | 0.233 | Acyl-CoA dehydrogenase inhibitor | 0.096 0.017 DBMET00023 0.16 0.008 DBMET03248 0.052 0.04 DBMET01102 0.073 0.025 DBMET01103 0.153 0.009 DBMET01126 0.084 0.021 DBMET01127 0.233 0.004 DBMET01146 0.084 0.021 DBMET01150 | DBMET01146 | |
| 0.096 | 0.252 | 0.724 | Succinate dehydrogenase inhibitor | 0.158 0.098 DBMET00022 0.564 0.003 DBMET00023 0.598 0.002 DBMET03248 0.216 0.037 DBMET00792 0.216 0.038 DBMET01102 0.285 0.013 DBMET01103 0.471 0.003 DBMET01126 0.193 0.055 DBMET01127 0.724 0.002 DBMET01146 0.193 0.055 DBMET01150 | DBMET01146 | |
| 0.049 | 0.215 | 0.41 | GABA C receptor antagonist | 0.099 0.079 DBMET00022 0.149 0.03 DBMET00023 0.198 0.013 DBMET03248 0.099 0.079 DBMET01103 0.257 0.006 DBMET01126 0.158 0.026 DBMET01127 0.41 0.003 DBMET01146 0.178 0.018 DBMET01150 | DBMET01146 | |
| 0.002 | 0.169 | 0.024 | Lysophosphatidic acid receptor 3 agonist | 0.024 0.004 DBMET03248 0.012 0.011 DBMET01126 0.022 0.005 DBMET01146 | DBMET03248 | |
| 0.044 | 0.213 | 0.742 | GABA C receptor agonist | 0.283 0.01 DBMET00023 0.36 0.006 DBMET03248 0.099 0.068 DBMET01102 0.214 0.018 DBMET01103 0.355 0.007 DBMET01126 0.143 0.037 DBMET01127 0.742 0.002 DBMET01146 0.163 0.029 DBMET01150 | DBMET01146 | |
| 0.044 | 0.214 | 0.245 | Glutathione S-transferase inhibitor | 0.125 0.02 DBMET00023 0.175 0.008 DBMET03248 0.128 0.019 DBMET00792 0.215 0.005 DBMET01100 0.235 0.004 DBMET01102 0.23 0.004 DBMET01103 0.13 0.018 DBMET01126 0.126 0.02 DBMET01127 0.245 0.004 DBMET01146 0.104 0.034 DBMET01150 | DBMET01146 | |
| 0.006 | 0.178 | 0.017 | Purinergic P2Y1 agonist | 0.017 0.009 DBMET03248 0.015 0.011 DBMET01146 | DBMET03248 | |
| 0.07 | 0.243 | 0.256 | Arachidonic acid antagonist | 0.144 0.095 DBMET00022 0.226 0.014 DBMET00023 0.256 0.005 DBMET03248 0.126 0.118 DBMET00792 0.181 0.052 DBMET01102 0.196 0.037 DBMET01103 0.209 0.025 DBMET01126 0.181 0.053 DBMET01127 0.253 0.005 DBMET01146 0.182 0.052 DBMET01150 | DBMET03248 | |
| 0.029 | 0.211 | 0.184 | ErbB-2 antagonist | 0.091 0.04 DBMET00021 0.116 0.029 DBMET00022 0.136 0.022 DBMET00792 0.184 0.011 DBMET01102 0.123 0.027 DBMET01103 | DBMET01102 | |
| 0.039 | 0.225 | 0.199 | Prolactin inhibitor | 0.197 0.009 DBMET00023 0.189 0.011 DBMET03248 0.182 0.012 DBMET01126 0.084 0.075 DBMET01127 0.199 0.009 DBMET01146 0.101 0.054 DBMET01150 | DBMET01146 | |
| 0.035 | 0.222 | 0.249 | Aminopeptidase B inhibitor | 0.24 0.014 DBMET00023 0.249 0.013 DBMET03248 0.111 0.058 DBMET00792 0.209 0.019 DBMET01100 0.126 0.049 DBMET01102 0.17 0.03 DBMET01103 0.155 0.035 DBMET01126 0.174 0.028 DBMET01127 0.196 0.022 DBMET01146 0.178 0.027 DBMET01150 | DBMET03248 | |
| 0.007 | 0.196 | 0.031 | Antibiotic Anthracycline-like | 0.021 0.01 DBMET00023 0.031 0.003 DBMET03248 0.019 0.013 DBMET01146 | DBMET03248 | |
| 0.013 | 0.204 | 0.098 | Endothelin-converting enzyme inhibitor | 0.087 0.016 DBMET01127 0.098 0.015 DBMET01150 | DBMET01150 | |
| 0.008 | 0.2 | 0.345 | Fumarate hydratase inhibitor | 0.047 0.015 DBMET00023 0.066 0.009 DBMET03248 0.046 0.015 DBMET01103 0.055 0.012 DBMET01126 0.035 0.023 DBMET01127 0.345 0.002 DBMET01146 0.035 0.023 DBMET01150 | DBMET01146 | |
| 0.048 | 0.242 | 0.403 | Bone formation stimulant | 0.105 0.101 DBMET00022 0.114 0.091 DBMET01100 0.184 0.04 DBMET01102 0.155 0.055 DBMET01103 0.156 0.054 DBMET01126 0.362 0.012 DBMET01127 0.122 0.084 DBMET01146 0.403 0.01 DBMET01150 | DBMET01150 | |
| 0.016 | 0.219 | 0.394 | Phosphofructokinase-1 inhibitor | 0.211 0.01 DBMET00023 0.23 0.009 DBMET03248 0.08 0.041 DBMET00792 0.081 0.04 DBMET01102 0.139 0.02 DBMET01103 0.291 0.006 DBMET01126 0.087 0.038 DBMET01127 0.394 0.003 DBMET01146 0.087 0.038 DBMET01150 | DBMET01146 | |
| 0.036 | 0.24 | 0.092 | Lipocortins synthesis agonist | 0.072 0.019 DBMET00023 0.092 0.008 DBMET03248 0.054 0.053 DBMET01102 0.056 0.046 DBMET01103 | DBMET03248 | |
| 0.009 | 0.217 | 0.041 | Vanilloid 2 agonist | 0.024 0.021 DBMET00023 0.026 0.016 DBMET03248 0.032 0.008 DBMET01126 0.041 0.004 DBMET01146 | DBMET01146 | |
| 0.005 | 0.215 | 0.022 | Telomerase stimulant | 0.017 0.013 DBMET00023 0.02 0.007 DBMET03248 0.016 0.015 DBMET01126 0.022 0.006 DBMET01146 | DBMET01146 | |
| 0.009 | 0.223 | 0.258 | Ornithine carbamoyltransferase inhibitor | 0.104 0.015 DBMET00023 0.114 0.014 DBMET03248 0.05 0.039 DBMET00792 0.066 0.028 DBMET01102 0.067 0.027 DBMET01103 0.192 0.007 DBMET01126 0.056 0.034 DBMET01127 0.258 0.005 DBMET01146 0.056 0.034 DBMET01150 | DBMET01146 | |
| 0.013 | 0.228 | 0.101 | Membrane dipeptidase inhibitor | 0.049 0.016 DBMET00023 0.065 0.008 DBMET03248 0.042 0.023 DBMET01103 0.053 0.014 DBMET01126 0.042 0.023 DBMET01127 0.101 0.004 DBMET01146 0.044 0.021 DBMET01150 | DBMET01146 | |
| 0.002 | 0.224 | 0.035 | Glutamate (mGluR6) agonist | 0.013 0.007 DBMET03248 0.035 0.003 DBMET01146 | DBMET01146 | |
| 0.016 | 0.243 | 0.093 | Alpha-mannosidase inhibitor | 0.079 0.012 DBMET00023 0.093 0.008 DBMET03248 0.075 0.014 DBMET01126 0.078 0.012 DBMET01146 | DBMET03248 | |
| 0.044 | 0.275 | 0.713 | Alpha-N-acetylglucosaminidase inhibitor | 0.655 0.003 DBMET00023 0.677 0.003 DBMET03248 0.138 0.063 DBMET00792 0.135 0.064 DBMET01102 0.173 0.044 DBMET01103 0.638 0.004 DBMET01126 0.142 0.059 DBMET01127 0.713 0.003 DBMET01146 0.16 0.049 DBMET01150 | DBMET01146 | |
| 0.037 | 0.268 | 0.165 | Anabolic | 0.144 0.021 DBMET00023 0.153 0.016 DBMET03248 0.146 0.02 DBMET01126 0.102 0.059 DBMET01127 0.165 0.011 DBMET01146 0.103 0.058 DBMET01150 | DBMET01146 | |
| 0.01 | 0.249 | 0.033 | Growth factor receptor-bound protein 2 antagonist | 0.032 0.031 DBMET01127 0.033 0.028 DBMET01150 | DBMET01150 | |
| 0.005 | 0.245 | 0.026 | Corticosteroid-like | 0.026 0.009 DBMET03248 | DBMET03248 | |
| 0.052 | 0.294 | 0.382 | Adenylate kinase inhibitor | 0.263 0.009 DBMET00023 0.223 0.012 DBMET03248 0.109 0.055 DBMET00792 0.094 0.079 DBMET01102 0.146 0.028 DBMET01103 0.355 0.004 DBMET01126 0.134 0.034 DBMET01127 0.382 0.004 DBMET01146 0.136 0.032 DBMET01150 | DBMET01146 | |
| 0.009 | 0.254 | 0.049 | Dopamine D5 agonist | 0.042 0.025 DBMET00023 0.048 0.019 DBMET03248 0.039 0.029 DBMET01126 0.049 0.018 DBMET01146 | DBMET01146 | |
| 0.016 | 0.264 | 0.222 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.15 0.009 DBMET00023 0.169 0.008 DBMET03248 0.222 0.006 DBMET01126 0.068 0.027 DBMET01127 0.205 0.006 DBMET01146 0.068 0.027 DBMET01150 | DBMET01126 | |
| 0.008 | 0.257 | 0.04 | Lysophosphatidic acid receptor 1 agonist | 0.035 0.007 DBMET03248 0.023 0.021 DBMET01103 0.024 0.019 DBMET01126 0.04 0.005 DBMET01146 | DBMET01146 | |
| 0.033 | 0.297 | 0.14 | Glutamate (mGluR6) antagonist | 0.079 0.026 DBMET00023 0.105 0.009 DBMET03248 0.076 0.029 DBMET01103 0.08 0.024 DBMET01126 0.067 0.047 DBMET01127 0.14 0.004 DBMET01146 0.068 0.044 DBMET01150 | DBMET01146 | |
| 0.116 | 0.381 | 0.44 | Tyrosine 3 hydroxylase inhibitor | 0.294 0.036 DBMET00023 0.348 0.016 DBMET03248 0.231 0.088 DBMET01103 0.295 0.036 DBMET01126 0.189 0.156 DBMET01127 0.44 0.005 DBMET01146 0.208 0.122 DBMET01150 | DBMET01146 | |
| 0.016 | 0.283 | 0.113 | Glutamate (mGluR8) agonist | 0.047 0.014 DBMET00023 0.055 0.009 DBMET03248 0.039 0.024 DBMET01103 0.051 0.011 DBMET01126 0.037 0.029 DBMET01127 0.113 0.003 DBMET01146 0.037 0.029 DBMET01150 | DBMET01146 | |
| 0.03 | 0.3 | 0.23 | Creatine kinase inhibitor | 0.13 0.034 DBMET00023 0.23 0.007 DBMET03248 0.117 0.043 DBMET01126 0.13 0.034 DBMET01127 0.2 0.01 DBMET01146 0.141 0.028 DBMET01150 | DBMET03248 | |
| 0.013 | 0.283 | 0.335 | Biliverdin reductase inhibitor | 0.096 0.02 DBMET00023 0.152 0.009 DBMET03248 0.074 0.029 DBMET01103 0.161 0.008 DBMET01126 0.067 0.034 DBMET01127 0.335 0.003 DBMET01146 0.067 0.034 DBMET01150 | DBMET01146 | |
| 0.01 | 0.285 | 0.082 | Mannosidase inhibitor | 0.066 0.014 DBMET00023 0.082 0.008 DBMET03248 0.063 0.015 DBMET01126 0.067 0.013 DBMET01146 | DBMET03248 | |
| 0.012 | 0.289 | 0.198 | Argininosuccinate synthase inhibitor | 0.176 0.009 DBMET00023 0.105 0.018 DBMET03248 0.069 0.031 DBMET01103 0.168 0.01 DBMET01126 0.056 0.04 DBMET01127 0.198 0.008 DBMET01146 0.056 0.04 DBMET01150 | DBMET01146 | |
| 0.119 | 0.41 | 0.234 | 5 Hydroxytryptamine 3E antagonist | 0.226 0.031 DBMET00023 0.216 0.04 DBMET03248 0.234 0.025 DBMET01126 0.187 0.088 DBMET01146 | DBMET01126 | |
| 0.096 | 0.394 | 0.192 | Ca2+-transporting ATPase inhibitor | 0.165 0.018 DBMET00023 0.187 0.005 DBMET03248 0.17 0.013 DBMET01126 0.192 0.004 DBMET01146 0.129 0.126 DBMET01150 | DBMET01146 | |
| 0.002 | 0.315 | 0.032 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.032 0.005 DBMET01103 0.017 0.009 DBMET01127 0.018 0.008 DBMET01150 | DBMET01103 | |
| 0.032 | 0.345 | 0.336 | GABA C receptor rho-1 antagonist | 0.124 0.036 DBMET00023 0.155 0.019 DBMET03248 0.232 0.005 DBMET01126 0.125 0.036 DBMET01127 0.336 0.003 DBMET01146 0.141 0.026 DBMET01150 | DBMET01146 | |
| 0.002 | 0.32 | 0.031 | Carbonic anhydrase X inhibitor | 0.017 0.011 DBMET00023 0.022 0.007 DBMET03248 0.016 0.013 DBMET01126 0.031 0.004 DBMET01146 | DBMET01146 | |
| 0.002 | 0.32 | 0.031 | Carbonic anhydrase VIII inhibitor | 0.017 0.011 DBMET00023 0.022 0.007 DBMET03248 0.016 0.013 DBMET01126 0.031 0.004 DBMET01146 | DBMET01146 | |
| 0.001 | 0.322 | 0.017 | Aminopeptidase A inhibitor | 0.017 0.013 DBMET01146 | DBMET01146 | |
| 0.014 | 0.337 | 0.567 | Porphobilinogen synthase inhibitor | 0.153 0.02 DBMET00023 0.172 0.016 DBMET03248 0.097 0.037 DBMET01103 0.241 0.008 DBMET01126 0.087 0.043 DBMET01127 0.567 0.003 DBMET01146 0.087 0.043 DBMET01150 | DBMET01146 | |
| 0.03 | 0.38 | 0.222 | Microtubule formation inhibitor | 0.17 0.029 DBMET00023 0.21 0.018 DBMET03248 0.191 0.022 DBMET01126 0.222 0.015 DBMET01146 | DBMET01146 | |
| 0.004 | 0.357 | 0.066 | Fructose-1,6-bisphosphatase inhibitor | 0.043 0.035 DBMET00023 0.066 0.014 DBMET03248 0.055 0.021 DBMET01127 0.056 0.02 DBMET01150 | DBMET03248 | |
| 0.013 | 0.37 | 0.459 | Glutamate decarboxylase inhibitor | 0.168 0.01 DBMET00023 0.157 0.012 DBMET03248 0.085 0.04 DBMET01103 0.245 0.004 DBMET01126 0.072 0.052 DBMET01127 0.459 0.003 DBMET01146 0.076 0.049 DBMET01150 | DBMET01146 | |
| 0.004 | 0.367 | 0.043 | Lysine carboxypeptidase inhibitor | 0.032 0.014 DBMET03248 0.043 0.009 DBMET01146 | DBMET01146 | |
| 0.001 | 0.364 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.006 DBMET00023 | DBMET00023 | |
| 0.002 | 0.366 | 0.012 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.012 0.011 DBMET01146 | DBMET01146 | |
| 0.005 | 0.37 | 0.065 | Guanylate cyclase inhibitor | 0.061 0.01 DBMET03248 0.041 0.032 DBMET01126 0.065 0.008 DBMET01146 | DBMET01146 | |
| 0.03 | 0.401 | 0.39 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.146 0.028 DBMET00023 0.241 0.01 DBMET03248 0.09 0.066 DBMET01103 0.178 0.02 DBMET01126 0.097 0.057 DBMET01127 0.39 0.004 DBMET01146 0.097 0.057 DBMET01150 | DBMET01146 | |
| 0.004 | 0.375 | 0.051 | Phosphoglycerate kinase inhibitor | 0.051 0.014 DBMET03248 0.042 0.018 DBMET01146 | DBMET03248 | |
| 0.008 | 0.388 | 0.525 | Alcohol oxidase inhibitor | 0.394 0.004 DBMET00023 0.422 0.004 DBMET03248 0.386 0.004 DBMET01126 0.525 0.004 DBMET01146 | DBMET01146 | |
| 0.01 | 0.398 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.1 0.032 DBMET00023 0.1 0.032 DBMET03248 0.123 0.015 DBMET01126 0.116 0.019 DBMET01146 | DBMET01126 | |
| 0.028 | 0.42 | 0.181 | Thioredoxin inhibitor | 0.179 0.011 DBMET00023 0.181 0.01 DBMET03248 0.084 0.073 DBMET01102 0.09 0.063 DBMET01103 0.096 0.053 DBMET01146 | DBMET03248 | |
| 0.005 | 0.399 | 0.028 | Acid ceramidase inhibitor | 0.027 0.015 DBMET00023 0.028 0.012 DBMET03248 | DBMET03248 | |
| 0.008 | 0.404 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.022 DBMET01146 | DBMET01146 | |
| 0.006 | 0.403 | 0.08 | GABA uptake inhibitor | 0.044 0.022 DBMET00023 0.057 0.012 DBMET03248 0.068 0.008 DBMET01126 0.08 0.005 DBMET01146 | DBMET01146 | |
| 0.01 | 0.407 | 0.08 | Adenosine deaminase inhibitor | 0.071 0.013 DBMET00023 0.08 0.009 DBMET03248 0.063 0.018 DBMET01126 0.065 0.016 DBMET01146 | DBMET03248 | |
| 0.003 | 0.401 | 0.033 | Isoleucine-tRNA ligase inhibitor | 0.023 0.014 DBMET00023 0.033 0.004 DBMET03248 0.028 0.007 DBMET01146 | DBMET03248 | |
| 0.037 | 0.435 | 0.098 | Glutamate (mGluR7) agonist | 0.092 0.078 DBMET03248 0.098 0.064 DBMET01146 | DBMET01146 | |
| 0.016 | 0.414 | 0.302 | GABA aminotransferase inhibitor | 0.136 0.011 DBMET00023 0.164 0.006 DBMET03248 0.069 0.063 DBMET01103 0.144 0.009 DBMET01126 0.302 0.003 DBMET01146 | DBMET01146 | |
| 0.023 | 0.422 | 0.119 | Sphingomyelinase inhibitor | 0.119 0.042 DBMET03248 0.097 0.063 DBMET01127 0.088 0.075 DBMET01146 0.105 0.055 DBMET01150 | DBMET03248 | |
| 0.005 | 0.406 | 0.108 | Carbonic anhydrase VB inhibitor | 0.066 0.03 DBMET03248 0.108 0.014 DBMET01146 | DBMET01146 | |
| 0.011 | 0.413 | 0.354 | Aconitate hydratase inhibitor | 0.078 0.014 DBMET00023 0.116 0.006 DBMET03248 0.053 0.035 DBMET01103 0.097 0.009 DBMET01126 0.354 0.002 DBMET01146 | DBMET01146 | |
| 0.003 | 0.406 | 0.027 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.027 0.011 DBMET03248 0.025 0.014 DBMET01127 0.022 0.02 DBMET01146 0.025 0.014 DBMET01150 | DBMET03248 | |
| 0.02 | 0.426 | 0.345 | Cystathionine beta-synthase inhibitor | 0.259 0.014 DBMET00023 0.345 0.007 DBMET03248 0.135 0.048 DBMET01126 0.285 0.011 DBMET01146 | DBMET03248 | |
| 0.082 | 0.489 | 0.667 | GABA C receptor rho-3 antagonist | 0.477 0.032 DBMET00023 0.479 0.032 DBMET03248 0.646 0.004 DBMET01126 0.233 0.17 DBMET01127 0.667 0.004 DBMET01146 0.267 0.14 DBMET01150 | DBMET01146 | |
| 0.013 | 0.422 | 0.075 | Dopamine beta hydroxylase inhibitor | 0.062 0.014 DBMET00023 0.062 0.013 DBMET03248 0.069 0.008 DBMET01126 0.075 0.006 DBMET01146 | DBMET01146 | |
| 0.019 | 0.432 | 0.18 | Ornithine decarboxylase inhibitor | 0.116 0.028 DBMET00023 0.121 0.025 DBMET03248 0.151 0.011 DBMET01126 0.18 0.006 DBMET01146 | DBMET01146 | |
| 0.005 | 0.422 | 0.058 | Prostaglandin F2 alpha agonist | 0.027 0.01 DBMET03248 0.027 0.011 DBMET01126 0.058 0.004 DBMET01146 | DBMET01146 | |
| 0.009 | 0.426 | 0.121 | Androgen agonist | 0.067 0.033 DBMET00023 0.121 0.01 DBMET03248 0.055 0.049 DBMET01126 0.074 0.028 DBMET01146 | DBMET03248 | |
| 0.013 | 0.431 | 0.154 | Kainate receptor agonist | 0.044 0.023 DBMET00023 0.051 0.013 DBMET03248 0.07 0.004 DBMET01126 0.154 0.002 DBMET01146 | DBMET01146 | |
| 0.052 | 0.472 | 0.187 | Vanilloid 1 agonist | 0.127 0.073 DBMET03248 0.113 0.105 DBMET00792 0.175 0.021 DBMET01102 0.161 0.029 DBMET01103 0.144 0.045 DBMET01126 0.126 0.074 DBMET01127 0.187 0.016 DBMET01146 0.116 0.097 DBMET01150 | DBMET01146 | |
| 0.005 | 0.426 | 0.035 | Purinergic P2Y15 antagonist | 0.032 0.014 DBMET00023 0.035 0.01 DBMET03248 0.029 0.02 DBMET01126 0.029 0.018 DBMET01146 | DBMET03248 | |
| 0.008 | 0.432 | 0.04 | Estrogen-related receptor gamma antagonist | 0.04 0.005 DBMET03248 | DBMET03248 | |
| 0.022 | 0.447 | 0.513 | Anesthetic general | 0.295 0.034 DBMET00023 0.489 0.009 DBMET03248 0.247 0.051 DBMET01102 0.328 0.027 DBMET01103 0.266 0.044 DBMET01126 0.151 0.113 DBMET01127 0.513 0.007 DBMET01146 0.181 0.086 DBMET01150 | DBMET01146 | |
| 0.07 | 0.496 | 0.274 | RNA-directed DNA polymerase inhibitor | 0.213 0.082 DBMET00023 0.252 0.048 DBMET03248 0.235 0.06 DBMET01126 0.21 0.085 DBMET01127 0.274 0.038 DBMET01146 0.218 0.076 DBMET01150 | DBMET01146 | |
| 0.045 | 0.471 | 0.261 | Adenylate cyclase stimulant | 0.142 0.078 DBMET00023 0.178 0.027 DBMET03248 0.201 0.013 DBMET01126 0.124 0.116 DBMET01127 0.261 0.004 DBMET01146 0.13 0.102 DBMET01150 | DBMET01146 | |
| 0.002 | 0.428 | 0.055 | Arginase inhibitor | 0.045 0.018 DBMET03248 0.055 0.012 DBMET01146 | DBMET01146 | |
| 0.028 | 0.456 | 0.336 | Amylase inhibitor | 0.314 0.017 DBMET00023 0.336 0.014 DBMET03248 0.27 0.023 DBMET01126 0.271 0.023 DBMET01146 | DBMET03248 | |
| 0.019 | 0.451 | 0.081 | Ryanodine receptor antagonist | 0.063 0.029 DBMET01126 0.081 0.008 DBMET01146 | DBMET01146 | |
| 0.069 | 0.501 | 0.374 | Vasodilator, coronary | 0.276 0.109 DBMET00023 0.374 0.045 DBMET03248 0.237 0.148 DBMET01126 0.305 0.083 DBMET01146 | DBMET03248 | |
| 0.006 | 0.439 | 0.028 | Thymidine phosphorylase inhibitor | 0.028 0.014 DBMET03248 0.025 0.02 DBMET01146 | DBMET03248 | |
| 0.022 | 0.462 | 0.193 | Glycine receptor agonist | 0.078 0.041 DBMET00023 0.118 0.013 DBMET03248 0.11 0.016 DBMET01126 0.193 0.004 DBMET01146 | DBMET01146 | |
| 0.005 | 0.448 | 0.08 | Thymidylate synthase inhibitor | 0.053 0.024 DBMET00023 0.053 0.024 DBMET03248 0.05 0.027 DBMET01103 0.046 0.032 DBMET01126 0.043 0.038 DBMET01127 0.08 0.007 DBMET01146 0.045 0.035 DBMET01150 | DBMET01146 | |
| 0.029 | 0.475 | 0.202 | Thioredoxin reductase inhibitor | 0.202 0.004 DBMET00023 0.126 0.015 DBMET03248 0.076 0.074 DBMET01102 0.128 0.014 DBMET01126 0.08 0.061 DBMET01146 | DBMET00023 | |
| 0.014 | 0.459 | 0.091 | Phospholipase D inhibitor | 0.068 0.057 DBMET00023 0.084 0.029 DBMET03248 0.072 0.048 DBMET01126 0.091 0.021 DBMET01146 | DBMET01146 | |
| 0.003 | 0.451 | 0.056 | Geranyltranstransferase inhibitor | 0.048 0.025 DBMET00023 0.049 0.024 DBMET03248 0.056 0.017 DBMET01126 0.044 0.031 DBMET01127 0.053 0.019 DBMET01146 0.046 0.027 DBMET01150 | DBMET01126 | |
| 0.017 | 0.469 | 0.102 | Purinergic P2X1 antagonist | 0.077 0.027 DBMET00023 0.084 0.023 DBMET03248 0.071 0.031 DBMET01126 0.102 0.016 DBMET01146 | DBMET01146 | |
| 0.008 | 0.459 | 0.049 | Prolyl endopeptidase inhibitor | 0.049 0.037 DBMET00023 0.047 0.041 DBMET01126 | DBMET00023 | |
| 0.002 | 0.454 | 0.026 | Thromboxane A2 agonist | 0.015 0.013 DBMET00023 0.02 0.005 DBMET03248 0.014 0.013 DBMET01126 0.026 0.004 DBMET01146 | DBMET01146 | |
| 0.001 | 0.453 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET01146 | DBMET01146 | |
| 0.028 | 0.481 | 0.181 | DOPA decarboxylase inhibitor | 0.134 0.032 DBMET00023 0.157 0.018 DBMET03248 0.128 0.037 DBMET01126 0.181 0.01 DBMET01146 | DBMET01146 | |
| 0.018 | 0.471 | 0.046 | Heme oxygenase inhibitor | 0.041 0.04 DBMET00023 0.045 0.023 DBMET03248 0.042 0.031 DBMET01126 0.046 0.021 DBMET01146 | DBMET01146 | |
| 0.039 | 0.497 | 0.349 | GABA C receptor rho-2 antagonist | 0.175 0.046 DBMET00023 0.198 0.03 DBMET03248 0.294 0.006 DBMET01126 0.349 0.004 DBMET01146 | DBMET01146 | |
| 0.008 | 0.47 | 0.133 | Lysophosphatidic acid 3 receptor antagonist | 0.06 0.023 DBMET03248 0.07 0.015 DBMET01126 0.133 0.003 DBMET01146 | DBMET01146 | |
| 0.002 | 0.465 | 0.062 | Uridine phosphorylase inhibitor | 0.054 0.007 DBMET03248 0.038 0.013 DBMET01126 0.062 0.005 DBMET01146 | DBMET01146 | |
| 0.009 | 0.472 | 0.067 | HCV NS3/NS4A protease inhibitor | 0.067 0.016 DBMET01126 0.066 0.017 DBMET01146 | DBMET01126 | |
| 0.002 | 0.468 | 0.021 | Nicotinic alpha4 receptor agonist | 0.021 0.006 DBMET01126 | DBMET01126 | |
| 0.023 | 0.492 | 0.26 | Cathepsin H inhibitor | 0.26 0.013 DBMET00023 0.191 0.025 DBMET03248 0.181 0.029 DBMET01126 0.143 0.051 DBMET01146 | DBMET00023 | |
| 0.014 | 0.483 | 0.145 | Glycine receptor antagonist | 0.082 0.054 DBMET00023 0.088 0.045 DBMET03248 0.117 0.02 DBMET01126 0.145 0.009 DBMET01146 | DBMET01146 | |
| 0.012 | 0.485 | 0.062 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.05 0.015 DBMET00023 0.061 0.007 DBMET03248 0.045 0.021 DBMET01126 0.062 0.007 DBMET01146 | DBMET01146 | |
| 0.009 | 0.482 | 0.333 | Histidine decarboxylase inhibitor | 0.084 0.04 DBMET00023 0.122 0.025 DBMET03248 0.084 0.04 DBMET01126 0.333 0.005 DBMET01146 | DBMET01146 | |
| 0.014 | 0.488 | 0.156 | Cathepsin G inhibitor | 0.156 0.02 DBMET00023 0.093 0.036 DBMET03248 0.085 0.04 DBMET01126 0.111 0.03 DBMET01146 | DBMET00023 | |
| 0.006 | 0.48 | 0.03 | Calcitonin receptor agonist | 0.03 0.027 DBMET03248 | DBMET03248 | |
| 0.002 | 0.479 | 0.018 | Vitamin D receptor agonist | 0.018 0.008 DBMET01146 | DBMET01146 | |
| 0.017 | 0.495 | 0.523 | Ferrochelatase inhibitor | 0.248 0.013 DBMET00023 0.281 0.009 DBMET03248 0.091 0.081 DBMET01103 0.331 0.005 DBMET01126 0.523 0.002 DBMET01146 | DBMET01146 | |
| 0.004 | 0.485 | 0.035 | Neuraminidase (Influenza B) inhibitor | 0.021 0.014 DBMET03248 0.026 0.007 DBMET01126 0.035 0.004 DBMET01146 | DBMET01146 | |
| 0.003 | 0.485 | 0.032 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.015 DBMET01126 | DBMET01126 | |
| 0.01 | 0.493 | 0.114 | Carbonic anhydrase VA inhibitor | 0.063 0.055 DBMET03248 0.114 0.02 DBMET01146 | DBMET01146 | |
| 0.01 | 0.495 | 0.055 | Thymidine kinase inhibitor | 0.055 0.015 DBMET03248 0.04 0.03 DBMET01126 0.054 0.017 DBMET01146 | DBMET03248 | |
| 0.006 | 0.494 | 0.044 | Toll-Like receptor 2 agonist | 0.043 0.027 DBMET03248 0.044 0.027 DBMET01146 | DBMET01146 | |
| 0.008 | 0.499 | 0.12 | Carbonic anhydrase V inhibitor | 0.058 0.057 DBMET03248 0.12 0.021 DBMET01146 | DBMET01146 | |
| 0.001 | 0.494 | 0.013 | Carbonic anhydrase XI inhibitor | 0.013 0.009 DBMET01146 | DBMET01146 | |
| 0.017 | 0.514 | 0.171 | Epidermal growth factor receptor kinase inhibitor | 0.104 0.093 DBMET01102 0.166 0.039 DBMET01126 0.171 0.037 DBMET01146 | DBMET01146 | |
| 0.001 | 0.499 | 0.015 | Thromboxane agonist | 0.01 0.009 DBMET03248 0.015 0.005 DBMET01146 | DBMET01146 | |
| 0.063 | 0.563 | 0.484 | 5 Hydroxytryptamine release stimulant | 0.245 0.091 DBMET00023 0.369 0.052 DBMET03248 0.401 0.046 DBMET01126 0.484 0.03 DBMET01146 | DBMET01146 | |
| 0.013 | 0.515 | 0.209 | Mucolytic | 0.135 0.042 DBMET03248 0.118 0.057 DBMET01126 0.209 0.011 DBMET01146 | DBMET01146 | |
| 0.031 | 0.532 | 0.103 | D-Ala-D-Ala ligase inhibitor | 0.085 0.054 DBMET00023 0.093 0.039 DBMET03248 0.079 0.071 DBMET01126 0.103 0.026 DBMET01146 | DBMET01146 | |
| 0.003 | 0.507 | 0.056 | Sodium/glucose cotransporter 2 inhibitor | 0.056 0.005 DBMET03248 | DBMET03248 | |
| 0.003 | 0.51 | 0.024 | Alpha 2b adrenoreceptor agonist | 0.024 0.006 DBMET01126 | DBMET01126 | |
| 0.023 | 0.53 | 0.101 | Vanilloid 4 agonist | 0.078 0.045 DBMET00023 0.085 0.032 DBMET03248 0.089 0.027 DBMET01126 0.101 0.016 DBMET01146 | DBMET01146 | |
| 0.008 | 0.518 | 0.041 | Ceramide glucosyltransferase inhibitor | 0.041 0.016 DBMET03248 | DBMET03248 | |
| 0.005 | 0.517 | 0.15 | Lysophosphatidic acid 2 receptor antagonist | 0.03 0.022 DBMET03248 0.033 0.018 DBMET01126 0.15 0.004 DBMET01146 | DBMET01146 | |
| 0.006 | 0.524 | 0.048 | Glutamate (mGluR3) agonist | 0.04 0.01 DBMET03248 0.048 0.005 DBMET01146 | DBMET01146 | |
| 0.002 | 0.525 | 0.138 | Retinoid X receptor agonist | 0.049 0.018 DBMET01126 0.138 0.003 DBMET01146 | DBMET01146 | |
| 0.024 | 0.547 | 0.114 | Granulocyte macrophage colony stimulating factor agonist | 0.104 0.03 DBMET00023 0.111 0.023 DBMET03248 0.105 0.029 DBMET01126 0.114 0.02 DBMET01146 | DBMET01146 | |
| 0.009 | 0.533 | 0.239 | Expectorant | 0.105 0.063 DBMET03248 0.095 0.075 DBMET01126 0.239 0.014 DBMET01146 | DBMET01146 | |
| 0.005 | 0.531 | 0.038 | Oxytocin agonist | 0.038 0.033 DBMET03248 | DBMET03248 | |
| 0.007 | 0.534 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.032 0.009 DBMET03248 0.027 0.017 DBMET01126 0.03 0.011 DBMET01146 | DBMET03248 | |
| 0.033 | 0.56 | 0.115 | Estrogen-related receptor beta agonist | 0.083 0.056 DBMET00023 0.115 0.012 DBMET03248 0.082 0.061 DBMET01126 0.103 0.022 DBMET01146 | DBMET03248 | |
| 0.012 | 0.542 | 0.284 | Cholesterol synthesis inhibitor | 0.128 0.058 DBMET00023 0.143 0.048 DBMET03248 0.187 0.03 DBMET01126 0.284 0.013 DBMET01146 | DBMET01146 | |
| 0.036 | 0.566 | 0.375 | Phospholipase C inhibitor | 0.14 0.129 DBMET00023 0.195 0.047 DBMET03248 0.141 0.126 DBMET01102 0.144 0.119 DBMET01103 0.202 0.042 DBMET01126 0.375 0.012 DBMET01146 | DBMET01146 | |
| 0.002 | 0.537 | 0.039 | Glutamate (mGluR1a) agonist | 0.029 0.009 DBMET00023 0.035 0.007 DBMET03248 0.039 0.006 DBMET01146 | DBMET01146 | |
| 0.016 | 0.551 | 0.109 | 5 Hydroxytryptamine 3A agonist | 0.109 0.066 DBMET00023 0.09 0.089 DBMET01126 | DBMET00023 | |
| 0.038 | 0.574 | 0.165 | DNA repair enzyme inhibitor | 0.132 0.052 DBMET00023 0.165 0.02 DBMET03248 0.118 0.077 DBMET01146 | DBMET03248 | |
| 0.105 | 0.643 | 0.456 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.456 0.058 DBMET00023 0.412 0.09 DBMET03248 0.436 0.071 DBMET01126 0.388 0.112 DBMET01146 | DBMET00023 | |
| 0.005 | 0.544 | 0.019 | Caspase 8 inhibitor | 0.019 0.014 DBMET00023 | DBMET00023 | |
| 0.008 | 0.546 | 0.317 | Phenylalanine 4-hydroxylase inhibitor | 0.069 0.048 DBMET00023 0.184 0.008 DBMET03248 0.107 0.023 DBMET01126 0.317 0.004 DBMET01146 | DBMET01146 | |
| 0.024 | 0.564 | 0.174 | Toll-Like receptor 4 antagonist | 0.146 0.023 DBMET03248 0.117 0.047 DBMET01103 0.09 0.089 DBMET01126 0.118 0.046 DBMET01127 0.174 0.011 DBMET01146 0.13 0.035 DBMET01150 | DBMET01146 | |
| 0.004 | 0.544 | 0.019 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.011 DBMET00023 0.019 0.007 DBMET03248 | DBMET03248 | |
| 0.009 | 0.551 | 0.094 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.084 0.03 DBMET00023 0.085 0.029 DBMET03248 0.091 0.021 DBMET01126 0.094 0.018 DBMET01146 | DBMET01146 | |
| 0.085 | 0.628 | 0.438 | 5 Hydroxytryptamine uptake stimulant | 0.289 0.051 DBMET00023 0.293 0.049 DBMET03248 0.346 0.027 DBMET01126 0.438 0.009 DBMET01146 | DBMET01146 | |
| 0.003 | 0.548 | 0.071 | Retinoid X beta receptor antagonist | 0.021 0.013 DBMET03248 0.026 0.006 DBMET01126 0.071 0.002 DBMET01146 | DBMET01146 | |
| 0.005 | 0.551 | 0.026 | Factor XIII inhibitor | 0.026 0.006 DBMET01126 0.022 0.011 DBMET01146 | DBMET01126 | |
| 0.013 | 0.562 | 0.077 | Histamine N-methyltransferase inhibitor | 0.077 0.07 DBMET03248 | DBMET03248 | |
| 0.019 | 0.574 | 0.243 | Protein kinase stimulant | 0.189 0.046 DBMET03248 0.133 0.081 DBMET01126 0.243 0.028 DBMET01146 | DBMET01146 | |
| 0.015 | 0.572 | 0.045 | Glucose-6-phosphate dehydrogenase inhibitor | 0.045 0.016 DBMET03248 | DBMET03248 | |
| 0.002 | 0.564 | 0.018 | Estrogen-related receptor gamma agonist | 0.018 0.015 DBMET03248 | DBMET03248 | |
| 0.004 | 0.565 | 0.035 | Alpha 1d adrenoreceptor agonist | 0.035 0.032 DBMET00023 | DBMET00023 | |
| 0.006 | 0.572 | 0.255 | Catalase inhibitor | 0.167 0.022 DBMET00023 0.183 0.019 DBMET03248 0.177 0.02 DBMET01126 0.255 0.008 DBMET01146 | DBMET01146 | |
| 0.003 | 0.569 | 0.151 | Retinoid X alpha receptor agonist | 0.04 0.02 DBMET01126 0.151 0.003 DBMET01146 | DBMET01146 | |
| 0.002 | 0.57 | 0.019 | Imidazoline I1 receptor antagonist | 0.019 0.017 DBMET01126 | DBMET01126 | |
| 0.004 | 0.578 | 0.03 | Thyroid hormone agonist | 0.03 0.013 DBMET01146 | DBMET01146 | |
| 0.07 | 0.645 | 0.254 | Nitric-oxide synthase stimulant | 0.223 0.057 DBMET00023 0.254 0.03 DBMET03248 0.204 0.082 DBMET01126 0.231 0.047 DBMET01146 | DBMET03248 | |
| 0.016 | 0.592 | 0.224 | Mannose-6-phosphate isomerase inhibitor | 0.224 0.02 DBMET00023 0.194 0.034 DBMET03248 0.206 0.027 DBMET01126 0.209 0.026 DBMET01146 | DBMET00023 | |
| 0.021 | 0.601 | 0.198 | Sphingosine 1-phosphate receptor 4 antagonist | 0.151 0.033 DBMET00023 0.198 0.009 DBMET03248 0.114 0.085 DBMET01127 0.14 0.044 DBMET01146 0.124 0.066 DBMET01150 | DBMET03248 | |
| 0.017 | 0.598 | 0.216 | Toll-Like receptor 2 antagonist | 0.147 0.054 DBMET03248 0.162 0.045 DBMET01126 0.216 0.017 DBMET01146 | DBMET01146 | |
| 0.007 | 0.589 | 0.053 | Squalene epoxidase inhibitor | 0.053 0.029 DBMET03248 0.047 0.04 DBMET01126 0.046 0.042 DBMET01146 | DBMET03248 | |
| 0.003 | 0.585 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.024 0.008 DBMET03248 0.021 0.013 DBMET01126 0.025 0.007 DBMET01146 | DBMET01146 | |
| 0.004 | 0.589 | 0.039 | Nerve growth factor antagonist | 0.039 0.038 DBMET00023 | DBMET00023 | |
| 0.008 | 0.594 | 0.03 | Hedgehog signaling activator | 0.03 0.012 DBMET03248 | DBMET03248 | |
| 0.024 | 0.611 | 0.471 | Peroxidase inhibitor | 0.25 0.047 DBMET00023 0.471 0.012 DBMET03248 0.22 0.054 DBMET01126 0.47 0.012 DBMET01146 | DBMET03248 | |
| 0.002 | 0.599 | 0.02 | Alpha 2c adrenoreceptor agonist | 0.02 0.011 DBMET01126 | DBMET01126 | |
| 0.005 | 0.603 | 0.039 | Integrin alpha2beta1 antagonist | 0.039 0.006 DBMET01146 | DBMET01146 | |
| 0.017 | 0.617 | 0.284 | Electrolyte absorption antagonist | 0.142 0.023 DBMET00023 0.164 0.015 DBMET03248 0.177 0.012 DBMET01126 0.284 0.004 DBMET01146 | DBMET01146 | |
| 0.014 | 0.615 | 0.202 | Keratolytic | 0.108 0.026 DBMET03248 0.07 0.065 DBMET01126 0.202 0.008 DBMET01146 | DBMET01146 | |
| 0.008 | 0.609 | 0.456 | Alcohol dehydrogenase inhibitor | 0.25 0.008 DBMET00023 0.456 0.004 DBMET03248 0.116 0.038 DBMET01126 0.135 0.026 DBMET01146 | DBMET03248 | |
| 0.006 | 0.608 | 0.041 | Melatonin receptor 1A agonist | 0.041 0.013 DBMET01126 0.04 0.014 DBMET01146 | DBMET01126 | |
| 0.003 | 0.605 | 0.04 | Sodium/glucose cotransporter inhibitor | 0.04 0.007 DBMET03248 | DBMET03248 | |
| 0.006 | 0.61 | 0.136 | Sphingosine 1-phosphate receptor 4 agonist | 0.101 0.024 DBMET03248 0.062 0.052 DBMET01103 0.061 0.053 DBMET01126 0.136 0.011 DBMET01146 | DBMET01146 | |
| 0.011 | 0.615 | 0.467 | Neurotrophic factor | 0.467 0.004 DBMET01126 | DBMET01126 | |
| 0.02 | 0.625 | 0.431 | TRPA1 agonist | 0.235 0.006 DBMET00023 0.152 0.03 DBMET03248 0.431 0.004 DBMET01126 0.209 0.009 DBMET01146 | DBMET01126 | |
| 0.031 | 0.637 | 0.262 | Neurotrophic factor enhancer | 0.147 0.143 DBMET00023 0.208 0.069 DBMET03248 0.169 0.111 DBMET01126 0.262 0.032 DBMET01146 | DBMET01146 | |
| 0.008 | 0.614 | 0.055 | AICAR transformylase inhibitor | 0.049 0.023 DBMET00023 0.049 0.024 DBMET01126 0.055 0.017 DBMET01146 | DBMET01146 | |
| 0.001 | 0.608 | 0.044 | Prostaglandin EP4 agonist | 0.044 0.005 DBMET01146 | DBMET01146 | |
| 0.008 | 0.62 | 0.064 | Sphingosine 1-phosphate receptor 1 antagonist | 0.064 0.024 DBMET03248 | DBMET03248 | |
| 0.013 | 0.625 | 0.049 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.046 DBMET01146 | DBMET01146 | |
| 0.007 | 0.623 | 0.1 | Adenylate cyclase 1 inhibitor | 0.053 0.023 DBMET03248 0.09 0.005 DBMET01126 0.1 0.004 DBMET01146 | DBMET01146 | |
| 0.006 | 0.625 | 0.07 | Sphingosine kinase 2 inhibitor | 0.07 0.022 DBMET03248 0.05 0.048 DBMET01146 | DBMET03248 | |
| 0.028 | 0.647 | 0.377 | 3C-like protease (Human coronavirus) inhibitor | 0.377 0.004 DBMET00023 0.281 0.016 DBMET03248 0.257 0.024 DBMET01126 0.15 0.1 DBMET01146 | DBMET00023 | |
| 0.001 | 0.621 | 0.024 | NMDA receptor glycine site antagonist | 0.024 0.018 DBMET03248 0.022 0.019 DBMET01146 | DBMET03248 | |
| 0.001 | 0.622 | 0.039 | Prostaglandin H2 antagonist | 0.039 0.006 DBMET01146 | DBMET01146 | |
| 0.007 | 0.632 | 0.069 | Retinoid X alpha receptor antagonist | 0.032 0.029 DBMET03248 0.037 0.018 DBMET01126 0.069 0.003 DBMET01146 | DBMET01146 | |
| 0.006 | 0.633 | 0.064 | Sphingosine 1-phosphate receptor 3 antagonist | 0.064 0.033 DBMET03248 | DBMET03248 | |
| 0.011 | 0.64 | 0.102 | GABA B receptor agonist | 0.071 0.064 DBMET00023 0.096 0.019 DBMET03248 0.102 0.015 DBMET01146 | DBMET01146 | |
| 0.009 | 0.639 | 0.086 | Interferon agonist | 0.086 0.043 DBMET03248 0.078 0.056 DBMET01146 | DBMET03248 | |
| 0.003 | 0.634 | 0.022 | CXC chemokine 5 receptor antagonist | 0.022 0.007 DBMET01146 | DBMET01146 | |
| 0.003 | 0.634 | 0.058 | ATP citrate lysase inhibitor | 0.058 0.005 DBMET01146 | DBMET01146 | |
| 0.021 | 0.655 | 0.189 | Cyclooxygenase 3 inhibitor | 0.144 0.054 DBMET03248 0.118 0.08 DBMET01126 0.189 0.023 DBMET01146 | DBMET01146 | |
| 0.009 | 0.645 | 0.071 | Pregnane X receptor antagonist | 0.065 0.022 DBMET00023 0.07 0.014 DBMET03248 0.066 0.02 DBMET01126 0.071 0.013 DBMET01146 | DBMET01146 | |
| 0.005 | 0.644 | 0.053 | Integrin alpha2 antagonist | 0.053 0.01 DBMET01146 | DBMET01146 | |
| 0.007 | 0.646 | 0.079 | Retinoid X receptor antagonist | 0.035 0.032 DBMET03248 0.042 0.021 DBMET01126 0.079 0.003 DBMET01146 | DBMET01146 | |
| 0.018 | 0.657 | 0.181 | Antiamyloidogenic | 0.181 0.113 DBMET00021 | DBMET00021 | |
| 0.01 | 0.65 | 0.072 | Interferon inducer | 0.072 0.033 DBMET03248 0.063 0.047 DBMET01146 | DBMET03248 | |
| 0.05 | 0.69 | 0.37 | Calcium channel activator | 0.255 0.142 DBMET00023 0.297 0.095 DBMET03248 0.311 0.081 DBMET01126 0.37 0.038 DBMET01146 | DBMET01146 | |
| 0.003 | 0.644 | 0.043 | Carbonic anhydrase VII inhibitor | 0.043 0.036 DBMET01146 | DBMET01146 | |
| 0.011 | 0.652 | 0.098 | Dihydroorotate oxidase inhibitor | 0.055 0.038 DBMET00023 0.062 0.025 DBMET03248 0.084 0.009 DBMET01126 0.098 0.005 DBMET01146 | DBMET01146 | |
| 0.014 | 0.66 | 0.366 | Spasmolytic | 0.249 0.091 DBMET03248 0.366 0.048 DBMET01146 | DBMET01146 | |
| 0.014 | 0.663 | 0.254 | Telomerase inhibitor | 0.078 0.045 DBMET03248 0.195 0.014 DBMET00792 0.254 0.009 DBMET01102 0.202 0.014 DBMET01103 0.234 0.011 DBMET01127 0.068 0.054 DBMET01150 | DBMET01102 | |
| 0.003 | 0.653 | 0.105 | NMDA receptor glycine site agonist | 0.087 0.024 DBMET03248 0.105 0.014 DBMET01146 | DBMET01146 | |
| 0.003 | 0.655 | 0.041 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.041 0.02 DBMET01126 0.039 0.022 DBMET01146 | DBMET01126 | |
| 0.018 | 0.672 | 0.645 | Aldehyde oxidase inhibitor | 0.34 0.057 DBMET00023 0.645 0.013 DBMET03248 0.279 0.072 DBMET01126 0.555 0.025 DBMET01146 | DBMET03248 | |
| 0.014 | 0.67 | 0.151 | Exportin-1 inhibitor | 0.091 0.014 DBMET00023 0.073 0.036 DBMET03248 0.142 0.004 DBMET01126 0.151 0.003 DBMET01146 | DBMET01146 | |
| 0.005 | 0.661 | 0.071 | Metalloproteinase-2 inhibitor | 0.071 0.064 DBMET01146 | DBMET01146 | |
| 0.017 | 0.674 | 0.102 | MAP kinase kinase 7 inhibitor | 0.091 0.023 DBMET03248 0.09 0.024 DBMET01126 0.102 0.012 DBMET01146 | DBMET01146 | |
| 0.03 | 0.688 | 0.519 | Superoxide dismutase inhibitor | 0.407 0.025 DBMET00023 0.362 0.034 DBMET03248 0.519 0.011 DBMET01126 0.498 0.013 DBMET01146 | DBMET01126 | |
| 0.009 | 0.668 | 0.193 | Prostaglandin dehydrogenase inhibitor | 0.193 0.161 DBMET01146 | DBMET01146 | |
| 0.002 | 0.662 | 0.064 | Dihydropteroate synthase inhibitor | 0.039 0.028 DBMET01126 0.064 0.01 DBMET01146 | DBMET01146 | |
| 0.01 | 0.671 | 0.069 | Glutamate (mGluR4) antagonist | 0.044 0.029 DBMET03248 0.069 0.01 DBMET01146 | DBMET01146 | |
| 0.002 | 0.67 | 0.03 | HCV NS5B polymerase inhibitor | 0.03 0.023 DBMET01146 | DBMET01146 | |
| 0.006 | 0.677 | 0.031 | Complement factor 1s inhibitor | 0.031 0.007 DBMET01126 0.027 0.014 DBMET01146 | DBMET01126 | |
| 0.002 | 0.673 | 0.069 | 5-Alpha-reductase inhibitor | 0.069 0.014 DBMET01146 | DBMET01146 | |
| 0.007 | 0.679 | 0.046 | Cytokine production stimulant | 0.046 0.041 DBMET03248 | DBMET03248 | |
| 0.009 | 0.682 | 0.087 | 5 Hydroxytryptamine 3 agonist | 0.087 0.022 DBMET01126 0.066 0.04 DBMET01146 | DBMET01126 | |
| 0.004 | 0.679 | 0.11 | Nicotinic alpha4beta2 receptor antagonist | 0.09 0.04 DBMET00023 0.072 0.059 DBMET03248 0.11 0.024 DBMET01126 0.086 0.044 DBMET01146 | DBMET01126 | |
| 0.005 | 0.682 | 0.143 | Epidermal growth factor antagonist | 0.094 0.049 DBMET01102 0.115 0.035 DBMET01126 0.143 0.025 DBMET01146 | DBMET01146 | |
| 0.008 | 0.686 | 0.04 | Vanilloid 3 antagonist | 0.037 0.029 DBMET03248 0.04 0.023 DBMET01146 | DBMET01146 | |
| 0.003 | 0.681 | 0.032 | Lysophosphatidic acid 1 receptor antagonist | 0.032 0.006 DBMET01146 | DBMET01146 | |
| 0.004 | 0.684 | 0.069 | Angiotensin-converting enzyme inhibitor | 0.069 0.021 DBMET01100 | DBMET01100 | |
| 0.004 | 0.683 | 0.05 | Leukotriene C4 antagonist | 0.05 0.011 DBMET01146 | DBMET01146 | |
| 0.024 | 0.704 | 0.065 | Calcium channel P-type blocker | 0.065 0.04 DBMET03248 | DBMET03248 | |
| 0.007 | 0.689 | 0.072 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.072 0.02 DBMET03248 0.056 0.034 DBMET01126 0.062 0.028 DBMET01146 | DBMET03248 | |
| 0.004 | 0.688 | 0.036 | 5 Hydroxytryptamine 2B agonist | 0.036 0.034 DBMET01126 | DBMET01126 | |
| 0.001 | 0.687 | 0.045 | Prostaglandin EP2 agonist | 0.045 0.007 DBMET01146 | DBMET01146 | |
| 0.002 | 0.69 | 0.047 | Nicotinic acid receptor 2 antagonist | 0.025 0.021 DBMET03248 0.035 0.008 DBMET01126 0.047 0.004 DBMET01146 | DBMET01146 | |
| 0.03 | 0.718 | 0.082 | CC chemokine 5 receptor agonist | 0.082 0.057 DBMET01126 0.08 0.066 DBMET01146 | DBMET01126 | |
| 0.014 | 0.703 | 0.093 | Phosphodiesterase I inhibitor | 0.093 0.054 DBMET03248 | DBMET03248 | |
| 0.043 | 0.732 | 0.157 | Catenin beta inhibitor | 0.157 0.091 DBMET01146 | DBMET01146 | |
| 0.007 | 0.697 | 0.041 | Potassium channel Kv1.1 blocker | 0.041 0.021 DBMET01126 | DBMET01126 | |
| 0.017 | 0.706 | 0.128 | Carbonic anhydrase XV inhibitor | 0.128 0.041 DBMET03248 0.102 0.064 DBMET01146 | DBMET03248 | |
| 0.006 | 0.696 | 0.146 | NMDA receptor agonist | 0.078 0.03 DBMET03248 0.146 0.009 DBMET01146 | DBMET01146 | |
| 0.013 | 0.704 | 0.196 | Adenylate cyclase inhibitor | 0.093 0.091 DBMET03248 0.109 0.077 DBMET01126 0.196 0.026 DBMET01146 | DBMET01146 | |
| 0.031 | 0.723 | 0.106 | Glutamate release inhibitor | 0.093 0.056 DBMET00023 0.106 0.035 DBMET03248 0.105 0.036 DBMET01146 | DBMET03248 | |
| 0.009 | 0.705 | 0.152 | Caspase 3 inhibitor | 0.152 0.027 DBMET00023 0.131 0.045 DBMET03248 0.106 0.082 DBMET00792 0.111 0.074 DBMET01103 0.135 0.041 DBMET01126 0.147 0.03 DBMET01146 | DBMET00023 | |
| 0.008 | 0.704 | 0.095 | Protease 3C (Human rhinovirus) inhibitor | 0.079 0.028 DBMET00023 0.095 0.018 DBMET01126 0.068 0.04 DBMET01146 | DBMET01126 | |
| 0.002 | 0.699 | 0.027 | 5-Alpha-reductase 2 inhibitor | 0.027 0.01 DBMET01146 | DBMET01146 | |
| 0.003 | 0.7 | 0.095 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.095 0.018 DBMET01146 | DBMET01146 | |
| 0.004 | 0.702 | 0.094 | Glutamate (mGluR1) agonist | 0.025 0.015 DBMET03248 0.03 0.01 DBMET01126 0.094 0.004 DBMET01146 | DBMET01146 | |
| 0.017 | 0.715 | 0.339 | Melanin inhibitor | 0.156 0.073 DBMET00023 0.151 0.08 DBMET03248 0.339 0.017 DBMET01126 0.259 0.027 DBMET01146 | DBMET01126 | |
| 0.014 | 0.712 | 0.285 | 5 Hydroxytryptamine 1E antagonist | 0.285 0.04 DBMET01126 0.251 0.074 DBMET01146 | DBMET01126 | |
| 0.001 | 0.701 | 0.016 | 5-Alpha-reductase 1 inhibitor | 0.016 0.013 DBMET01146 | DBMET01146 | |
| 0.002 | 0.702 | 0.11 | Kainate receptor 2 antagonist | 0.04 0.022 DBMET01126 0.11 0.004 DBMET01146 | DBMET01146 | |
| 0.044 | 0.744 | 0.731 | Caspase 9 stimulant | 0.296 0.198 DBMET00023 0.389 0.117 DBMET03248 0.491 0.063 DBMET01126 0.731 0.02 DBMET01146 0.267 0.232 DBMET01150 | DBMET01146 | |
| 0.004 | 0.706 | 0.073 | Leukotriene C antagonist | 0.055 0.042 DBMET03248 0.073 0.012 DBMET01146 | DBMET01146 | |
| 0.011 | 0.714 | 0.074 | CD45 antagonist | 0.074 0.014 DBMET01146 | DBMET01146 | |
| 0.004 | 0.708 | 0.088 | Caspase 2 inhibitor | 0.088 0.005 DBMET00023 0.03 0.023 DBMET03248 | DBMET00023 | |
| 0.009 | 0.714 | 0.123 | Carbonic anhydrase XIII inhibitor | 0.067 0.062 DBMET00023 0.069 0.059 DBMET03248 0.088 0.044 DBMET01126 0.123 0.028 DBMET01146 | DBMET01146 | |
| 0.005 | 0.71 | 0.053 | Epithelial sodium channel blocker | 0.053 0.042 DBMET03248 0.052 0.045 DBMET01146 | DBMET03248 | |
| 0.004 | 0.709 | 0.053 | AMPA 4 receptor antagonist | 0.053 0.013 DBMET01146 | DBMET01146 | |
| 0.012 | 0.719 | 0.173 | Proteasome inhibitor | 0.173 0.035 DBMET00023 0.13 0.058 DBMET03248 0.167 0.037 DBMET01126 0.116 0.069 DBMET01146 | DBMET00023 | |
| 0.006 | 0.719 | 0.135 | CYP2A6 inhibitor | 0.069 0.06 DBMET00023 0.135 0.021 DBMET01126 0.089 0.042 DBMET01146 | DBMET01126 | |
| 0.021 | 0.736 | 0.577 | Cholesterol antagonist | 0.25 0.125 DBMET00023 0.419 0.046 DBMET03248 0.32 0.079 DBMET01126 0.577 0.022 DBMET01146 | DBMET01146 | |
| 0.014 | 0.73 | 0.259 | HIV-1 integrase (Overall Integration) inhibitor | 0.139 0.029 DBMET03248 0.129 0.035 DBMET01126 0.259 0.005 DBMET01146 | DBMET01146 | |
| 0.001 | 0.719 | 0.065 | Kainate receptor 1 antagonist | 0.065 0.005 DBMET01146 | DBMET01146 | |
| 0.014 | 0.733 | 0.086 | mTOR complex 2 inhibitor | 0.086 0.055 DBMET03248 | DBMET03248 | |
| 0.006 | 0.727 | 0.062 | Glutamate (mGluR group III) antagonist | 0.062 0.012 DBMET01146 | DBMET01146 | |
| 0.017 | 0.739 | 0.067 | Transcription factor RelA inhibitor | 0.067 0.036 DBMET01126 0.064 0.042 DBMET01146 | DBMET01126 | |
| 0.006 | 0.729 | 0.069 | Carbonic anhydrase stimulant | 0.069 0.032 DBMET01146 | DBMET01146 | |
| 0.024 | 0.748 | 0.308 | Interleukin agonist | 0.247 0.081 DBMET03248 0.164 0.154 DBMET01126 0.308 0.044 DBMET01146 | DBMET01146 | |
| 0.006 | 0.731 | 0.099 | Glutamate (mGluR7) antagonist | 0.073 0.037 DBMET00023 0.067 0.048 DBMET03248 0.073 0.038 DBMET01126 0.099 0.011 DBMET01146 | DBMET01146 | |
| 0.003 | 0.734 | 0.045 | GABA B receptor antagonist | 0.045 0.026 DBMET01146 | DBMET01146 | |
| 0.015 | 0.745 | 0.257 | Cyclic AMP phosphodiesterase inhibitor | 0.257 0.06 DBMET03248 0.202 0.092 DBMET01146 | DBMET03248 | |
| 0.007 | 0.74 | 0.148 | Sphingosine 1-phosphate receptor 2 antagonist | 0.145 0.048 DBMET03248 0.148 0.043 DBMET01146 | DBMET01146 | |
| 0.009 | 0.743 | 0.086 | Estrogen receptor alpha antagonist | 0.073 0.06 DBMET03248 0.086 0.04 DBMET01146 | DBMET01146 | |
| 0.003 | 0.738 | 0.054 | Carbonic anhydrase XIV inhibitor | 0.054 0.029 DBMET01146 | DBMET01146 | |
| 0 | 0.737 | 0.018 | G-protein-coupled receptor 120 agonist | 0.018 0.011 DBMET01146 | DBMET01146 | |
| 0.005 | 0.743 | 0.06 | Glutamate (mGluR group III) agonist | 0.06 0.018 DBMET01146 | DBMET01146 | |
| 0.012 | 0.751 | 0.284 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.156 0.136 DBMET00023 0.218 0.059 DBMET03248 0.155 0.138 DBMET01126 0.284 0.029 DBMET01146 | DBMET01146 | |
| 0.013 | 0.754 | 0.055 | Immunoglobulin Fc receptor antagonist | 0.055 0.04 DBMET03248 | DBMET03248 | |
| 0.017 | 0.759 | 0.217 | Photosensitizer | 0.102 0.085 DBMET00023 0.125 0.052 DBMET03248 0.15 0.031 DBMET01126 0.217 0.01 DBMET01146 | DBMET01146 | |
| 0.003 | 0.746 | 0.038 | Glutamate (mGluR4) agonist | 0.038 0.018 DBMET01146 | DBMET01146 | |
| 0.013 | 0.758 | 0.17 | Carbonic anhydrase III inhibitor | 0.112 0.051 DBMET03248 0.17 0.022 DBMET01146 | DBMET01146 | |
| 0.003 | 0.748 | 0.04 | Sphingosine kinase 1 inhibitor | 0.04 0.031 DBMET03248 | DBMET03248 | |
| 0.002 | 0.748 | 0.048 | CDK5/p25 inhibitor | 0.048 0.023 DBMET03248 | DBMET03248 | |
| 0.001 | 0.748 | 0.057 | Kynurenine 3 monooxygenase inhibitor | 0.057 0.005 DBMET01146 | DBMET01146 | |
| 0.003 | 0.75 | 0.076 | NMDA receptor antagonist | 0.076 0.07 DBMET01146 | DBMET01146 | |
| 0.016 | 0.764 | 0.135 | Lanosterol 14 alpha demethylase inhibitor | 0.109 0.043 DBMET03248 0.111 0.04 DBMET01126 0.135 0.018 DBMET01146 | DBMET01146 | |
| 0.001 | 0.753 | 0.04 | Free fatty acid receptor 1 antagonist | 0.04 0.016 DBMET01146 | DBMET01146 | |
| 0.011 | 0.763 | 0.134 | Carbonic anhydrase VI inhibitor | 0.085 0.052 DBMET03248 0.134 0.025 DBMET01146 | DBMET01146 | |
| 0.012 | 0.765 | 0.163 | Sphingosine 1-phosphate receptor 5 antagonist | 0.163 0.042 DBMET03248 0.158 0.049 DBMET01146 | DBMET03248 | |
| 0.002 | 0.757 | 0.096 | NMDA 2C receptor antagonist | 0.096 0.017 DBMET01146 | DBMET01146 | |
| 0.002 | 0.758 | 0.045 | Oleamide hydrolase inhibitor | 0.045 0.032 DBMET00023 0.043 0.034 DBMET01126 | DBMET00023 | |
| 0.003 | 0.759 | 0.054 | Glutamate (mGluR3) antagonist | 0.039 0.022 DBMET03248 0.054 0.01 DBMET01146 | DBMET01146 | |
| 0.005 | 0.761 | 0.08 | Sphingosine 1-phosphate receptor antagonist | 0.08 0.046 DBMET03248 | DBMET03248 | |
| 0.002 | 0.759 | 0.046 | Diamine oxidase inhibitor | 0.046 0.017 DBMET01146 | DBMET01146 | |
| 0.002 | 0.759 | 0.112 | Kainate receptor antagonist | 0.112 0.006 DBMET01146 | DBMET01146 | |
| 0.002 | 0.76 | 0.053 | NMDA 2A receptor antagonist | 0.053 0.035 DBMET01146 | DBMET01146 | |
| 0.012 | 0.775 | 0.059 | Antiviral (Hepatitis D) | 0.059 0.023 DBMET01102 0.048 0.042 DBMET01127 0.055 0.028 DBMET01150 | DBMET01102 | |
| 0.011 | 0.777 | 0.312 | Aldehyde dehydrogenase inhibitor | 0.195 0.029 DBMET00023 0.163 0.04 DBMET03248 0.312 0.01 DBMET01126 0.27 0.015 DBMET01146 | DBMET01126 | |
| 0.001 | 0.767 | 0.011 | Integrin beta2 antagonist | 0.011 0.01 DBMET01146 | DBMET01146 | |
| 0.006 | 0.772 | 0.156 | Falcipain 3 inhibitor | 0.14 0.041 DBMET00023 0.087 0.085 DBMET03248 0.156 0.034 DBMET01126 | DBMET01126 | |
| 0.003 | 0.772 | 0.101 | Protein kinase (CK2) alpha inhibitor | 0.101 0.076 DBMET03248 | DBMET03248 | |
| 0.004 | 0.773 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.052 DBMET03248 | DBMET03248 | |
| 0.018 | 0.788 | 0.272 | Interferon gamma antagonist | 0.135 0.101 DBMET00023 0.172 0.056 DBMET03248 0.18 0.05 DBMET01126 0.272 0.024 DBMET01146 | DBMET01146 | |
| 0.001 | 0.77 | 0.046 | Prostaglandin E2 agonist | 0.046 0.006 DBMET01146 | DBMET01146 | |
| 0.013 | 0.784 | 0.2 | Neurotensin receptor agonist | 0.159 0.081 DBMET00023 0.182 0.047 DBMET03248 0.14 0.129 DBMET01126 0.2 0.034 DBMET01146 | DBMET01146 | |
| 0.004 | 0.775 | 0.099 | Acetylcholine M2 receptor agonist | 0.099 0.007 DBMET01077 | DBMET01077 | |
| 0.002 | 0.774 | 0.045 | NMDA receptor subunit 3A antagonist | 0.045 0.022 DBMET01146 | DBMET01146 | |
| 0.006 | 0.779 | 0.059 | Beta 3 adrenoreceptor antagonist | 0.059 0.058 DBMET03248 | DBMET03248 | |
| 0.002 | 0.775 | 0.055 | NMDA receptor subunit 3B antagonist | 0.055 0.022 DBMET01146 | DBMET01146 | |
| 0.002 | 0.777 | 0.096 | Leukotriene B4 antagonist | 0.096 0.011 DBMET01146 | DBMET01146 | |
| 0.001 | 0.776 | 0.079 | Prostaglandin agonist | 0.079 0.007 DBMET01146 | DBMET01146 | |
| 0.001 | 0.777 | 0.041 | Methionyl aminopeptidase 1 inhibitor | 0.03 0.026 DBMET01126 0.041 0.011 DBMET01146 | DBMET01146 | |
| 0.043 | 0.819 | 0.277 | Heat shock protein 70 antagonist | 0.141 0.071 DBMET03248 0.157 0.032 DBMET01126 0.277 0.004 DBMET01146 | DBMET01146 | |
| 0.005 | 0.784 | 0.041 | CF transmembrane conductance regulator antagonist | 0.038 0.033 DBMET03248 0.041 0.023 DBMET01146 | DBMET01146 | |
| 0.002 | 0.781 | 0.041 | AMPA 3 receptor antagonist | 0.041 0.013 DBMET01146 | DBMET01146 | |
| 0.004 | 0.785 | 0.061 | Heparanase inhibitor | 0.061 0.021 DBMET01146 | DBMET01146 | |
| 0.004 | 0.785 | 0.18 | Cytidine deaminase inhibitor | 0.112 0.11 DBMET03248 0.155 0.071 DBMET01126 0.18 0.057 DBMET01146 | DBMET01146 | |
| 0.003 | 0.785 | 0.061 | Sphingosine kinase inhibitor | 0.061 0.037 DBMET03248 | DBMET03248 | |
| 0.002 | 0.786 | 0.065 | Aromatase inhibitor | 0.065 0.038 DBMET01126 | DBMET01126 | |
| 0.002 | 0.787 | 0.032 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.032 0.027 DBMET01146 | DBMET01146 | |
| 0.003 | 0.788 | 0.092 | Amidase inhibitor | 0.079 0.038 DBMET00023 0.092 0.029 DBMET01126 | DBMET01126 | |
| 0.003 | 0.789 | 0.06 | Fibroblast growth factor 2 antagonist | 0.06 0.052 DBMET03248 | DBMET03248 | |
| 0.025 | 0.814 | 0.48 | 5 Hydroxytryptamine release inhibitor | 0.327 0.136 DBMET00023 0.48 0.039 DBMET03248 0.295 0.17 DBMET01126 0.441 0.056 DBMET01146 | DBMET03248 | |
| 0.002 | 0.793 | 0.06 | Potassium channel Kv1.3 blocker | 0.06 0.021 DBMET01126 0.059 0.022 DBMET01146 | DBMET01126 | |
| 0.003 | 0.797 | 0.031 | Trypsin II inhibitor | 0.031 0.019 DBMET00023 | DBMET00023 | |
| 0.002 | 0.797 | 0.056 | Phosphorylase inhibitor | 0.056 0.027 DBMET01146 | DBMET01146 | |
| 0.003 | 0.799 | 0.077 | Nicotinic acid receptor agonist | 0.071 0.008 DBMET03248 0.077 0.007 DBMET01146 | DBMET01146 | |
| 0.004 | 0.801 | 0.145 | Anesthetic local | 0.145 0.051 DBMET01126 0.132 0.058 DBMET01146 | DBMET01126 | |
| 0.01 | 0.808 | 0.107 | Acetylcholine release stimulant | 0.098 0.093 DBMET03248 0.106 0.074 DBMET01126 0.107 0.071 DBMET01146 | DBMET01146 | |
| 0.004 | 0.803 | 0.042 | Tryptophan 5 hydroxylase inhibitor | 0.042 0.013 DBMET01146 | DBMET01146 | |
| 0.002 | 0.801 | 0.043 | Dihydrofolate reductase inhibitor | 0.043 0.032 DBMET03248 0.041 0.036 DBMET01146 | DBMET03248 | |
| 0.004 | 0.804 | 0.279 | Calpain inhibitor | 0.279 0.042 DBMET00023 0.234 0.081 DBMET03248 0.236 0.078 DBMET01126 | DBMET00023 | |
| 0.003 | 0.807 | 0.048 | Factor XIIIa inhibitor | 0.04 0.023 DBMET01126 0.048 0.017 DBMET01146 | DBMET01146 | |
| 0.001 | 0.805 | 0.054 | Peroxisome proliferator-activated receptor delta agonist | 0.054 0.011 DBMET01146 | DBMET01146 | |
| 0.011 | 0.819 | 0.132 | Vanilloid agonist | 0.132 0.014 DBMET01102 0.106 0.027 DBMET01103 0.086 0.055 DBMET01127 0.121 0.018 DBMET01146 | DBMET01102 | |
| 0.002 | 0.813 | 0.079 | Thromboxane A2 antagonist | 0.079 0.015 DBMET01146 | DBMET01146 | |
| 0.001 | 0.815 | 0.027 | AMPA 1 receptor antagonist | 0.027 0.022 DBMET01146 | DBMET01146 | |
| 0.004 | 0.821 | 0.184 | Psychostimulant | 0.184 0.09 DBMET01146 | DBMET01146 | |
| 0.004 | 0.822 | 0.058 | Glucosylceramidase inhibitor | 0.058 0.033 DBMET03248 0.051 0.045 DBMET01126 | DBMET03248 | |
| 0.016 | 0.838 | 0.185 | CF transmembrane conductance regulator agonist | 0.134 0.108 DBMET00023 0.138 0.099 DBMET03248 0.184 0.033 DBMET01126 0.185 0.032 DBMET01146 | DBMET01146 | |
| 0.004 | 0.827 | 0.419 | Calpain 2 inhibitor | 0.419 0.051 DBMET00023 0.247 0.152 DBMET03248 0.318 0.103 DBMET01126 | DBMET00023 | |
| 0.002 | 0.825 | 0.09 | Squalene synthetase inhibitor | 0.09 0.007 DBMET01146 | DBMET01146 | |
| 0.013 | 0.836 | 0.075 | Antineoplastic alkaloid | 0.075 0.073 DBMET01146 | DBMET01146 | |
| 0.001 | 0.827 | 0.03 | Liver X receptor beta antagonist | 0.03 0.019 DBMET01146 | DBMET01146 | |
| 0.004 | 0.831 | 0.193 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.162 0.129 DBMET03248 0.193 0.104 DBMET01146 | DBMET01146 | |
| 0.002 | 0.831 | 0.085 | Thromboxane antagonist | 0.085 0.017 DBMET01146 | DBMET01146 | |
| 0.007 | 0.836 | 0.523 | Transcription factor NF kappa B inhibitor | 0.289 0.1 DBMET00023 0.262 0.119 DBMET03248 0.468 0.049 DBMET01126 0.523 0.041 DBMET01146 | DBMET01146 | |
| 0.001 | 0.832 | 0.068 | Peroxisome proliferator-activated receptor alpha agonist | 0.068 0.023 DBMET01146 | DBMET01146 | |
| 0.003 | 0.835 | 0.209 | Phospholipase A2 inhibitor | 0.209 0.038 DBMET01146 | DBMET01146 | |
| 0.002 | 0.837 | 0.045 | RNA-directed RNA polymerase inhibitor | 0.045 0.015 DBMET01146 | DBMET01146 | |
| 0.004 | 0.839 | 0.176 | Androgen antagonist | 0.091 0.054 DBMET00023 0.176 0.017 DBMET03248 0.077 0.069 DBMET01146 | DBMET03248 | |
| 0.007 | 0.844 | 0.203 | Thiol protease inhibitor | 0.189 0.043 DBMET00023 0.14 0.08 DBMET03248 0.203 0.038 DBMET01126 0.165 0.057 DBMET01146 | DBMET01126 | |
| 0.006 | 0.843 | 0.134 | Pregnane X receptor agonist | 0.127 0.109 DBMET03248 0.127 0.107 DBMET01126 0.134 0.089 DBMET01146 | DBMET01146 | |
| 0.004 | 0.843 | 0.095 | Caspase 7 inhibitor | 0.095 0.034 DBMET00023 0.077 0.069 DBMET03248 0.092 0.038 DBMET01126 0.081 0.058 DBMET01146 | DBMET00023 | |
| 0.002 | 0.842 | 0.058 | Cathepsin L inhibitor | 0.058 0.041 DBMET00023 | DBMET00023 | |
| 0.009 | 0.85 | 0.112 | Bile acid receptor antagonist | 0.09 0.074 DBMET03248 0.112 0.028 DBMET01146 | DBMET01146 | |
| 0.005 | 0.85 | 0.063 | Cyclin D1 inhibitor | 0.063 0.039 DBMET01126 | DBMET01126 | |
| 0.002 | 0.847 | 0.032 | LFA antagonist | 0.032 0.013 DBMET01146 | DBMET01146 | |
| 0.002 | 0.849 | 0.032 | Angiotensin II receptor antagonist | 0.032 0.027 DBMET01146 | DBMET01146 | |
| 0.002 | 0.849 | 0.04 | Leukocyte elastase inhibitor | 0.04 0.033 DBMET01146 | DBMET01146 | |
| 0.01 | 0.858 | 0.113 | Phosphodiesterase 6D inhibitor | 0.089 0.077 DBMET01126 0.113 0.032 DBMET01146 | DBMET01146 | |
| 0.003 | 0.851 | 0.079 | Thromboxane synthase inhibitor | 0.079 0.012 DBMET01146 | DBMET01146 | |
| 0.013 | 0.862 | 0.357 | Insulysin inhibitor | 0.192 0.169 DBMET00023 0.219 0.131 DBMET03248 0.284 0.069 DBMET01126 0.357 0.032 DBMET01146 | DBMET01146 | |
| 0.002 | 0.851 | 0.21 | Monophenol monooxygenase inhibitor | 0.095 0.08 DBMET01126 0.21 0.031 DBMET01146 | DBMET01146 | |
| 0.001 | 0.85 | 0.036 | Progesterone antagonist | 0.036 0.025 DBMET01146 | DBMET01146 | |
| 0.004 | 0.853 | 0.126 | Alkaline phosphatase inhibitor | 0.126 0.079 DBMET01146 | DBMET01146 | |
| 0.014 | 0.864 | 0.162 | Hexokinase inhibitor | 0.143 0.087 DBMET00023 0.14 0.091 DBMET03248 0.162 0.065 DBMET01126 0.158 0.07 DBMET01146 | DBMET01126 | |
| 0.001 | 0.853 | 0.044 | Angiotensin AT1 receptor antagonist | 0.044 0.026 DBMET01146 | DBMET01146 | |
| 0.001 | 0.852 | 0.042 | Urate transporter 1 inhibitor | 0.042 0.024 DBMET01146 | DBMET01146 | |
| 0.008 | 0.86 | 0.133 | Antibacterial (Helicobacter pylori) | 0.112 0.095 DBMET03248 0.133 0.063 DBMET01146 | DBMET01146 | |
| 0.005 | 0.859 | 0.099 | AMP-activated protein kinase stimulant | 0.099 0.072 DBMET01146 | DBMET01146 | |
| 0.002 | 0.857 | 0.029 | ICAM 1 antagonist | 0.029 0.007 DBMET01146 | DBMET01146 | |
| 0.013 | 0.87 | 0.145 | MAP kinase 3 inhibitor | 0.133 0.1 DBMET03248 0.129 0.109 DBMET01126 0.145 0.076 DBMET01146 | DBMET01146 | |
| 0.004 | 0.863 | 0.06 | Botulinum neurotoxin type A inhibitor | 0.06 0.038 DBMET01146 | DBMET01146 | |
| 0.008 | 0.868 | 0.154 | Interleukin 8 antagonist | 0.154 0.032 DBMET01146 | DBMET01146 | |
| 0.005 | 0.868 | 0.103 | Beta glucuronidase inhibitor | 0.103 0.066 DBMET01126 0.09 0.088 DBMET01146 | DBMET01126 | |
| 0.008 | 0.872 | 0.261 | Hypoxia-inducible factor 1 alpha inhibitor | 0.261 0.09 DBMET00023 0.23 0.118 DBMET03248 0.209 0.141 DBMET01126 0.23 0.119 DBMET01146 | DBMET00023 | |
| 0.006 | 0.871 | 0.086 | MDM2 inhibitor | 0.071 0.036 DBMET03248 0.086 0.014 DBMET01146 | DBMET01146 | |
| 0.018 | 0.884 | 0.518 | Histamine release inhibitor | 0.379 0.086 DBMET03248 0.255 0.152 DBMET01126 0.518 0.023 DBMET01146 | DBMET01146 | |
| 0.01 | 0.877 | 0.167 | NADPH oxidase inhibitor | 0.163 0.047 DBMET00023 0.167 0.045 DBMET01126 0.114 0.091 DBMET01146 | DBMET01126 | |
| 0.005 | 0.872 | 0.102 | Plasminogen activator inhibitor | 0.102 0.015 DBMET00023 | DBMET00023 | |
| 0.006 | 0.875 | 0.467 | Antithrombotic | 0.276 0.106 DBMET00023 0.274 0.108 DBMET03248 0.326 0.074 DBMET01126 0.467 0.034 DBMET01146 | DBMET01146 | |
| 0.003 | 0.874 | 0.132 | Macrophage migration inhibitory factor inhibitor | 0.132 0.021 DBMET01146 | DBMET01146 | |
| 0.005 | 0.876 | 0.616 | Thioredoxin glutathione reductase inhibitor | 0.616 0.014 DBMET00023 0.469 0.035 DBMET03248 | DBMET00023 | |
| 0.003 | 0.876 | 0.065 | Potassium channel (ATP-sensitive) blocker | 0.065 0.05 DBMET03248 | DBMET03248 | |
| 0.004 | 0.877 | 0.136 | Interleukin 1 beta converting enzyme inhibitor | 0.126 0.031 DBMET00023 0.089 0.073 DBMET03248 0.136 0.024 DBMET01126 0.136 0.024 DBMET01146 | DBMET01146 | |
| 0.001 | 0.877 | 0.106 | Leukotriene antagonist | 0.106 0.019 DBMET01146 | DBMET01146 | |
| 0.005 | 0.882 | 0.154 | Xanthine oxidase inhibitor | 0.139 0.039 DBMET03248 0.095 0.064 DBMET01126 0.154 0.033 DBMET01146 | DBMET01146 | |
| 0.002 | 0.878 | 0.341 | TRPA1 antagonist | 0.077 0.027 DBMET00023 0.341 0.004 DBMET01126 | DBMET01126 | |
| 0.002 | 0.88 | 0.093 | Xanthine dehydrogenase inhibitor | 0.093 0.018 DBMET01126 0.093 0.018 DBMET01146 | DBMET01146 | |
| 0.001 | 0.88 | 0.036 | Prostaglandin EP4 antagonist | 0.036 0.012 DBMET01146 | DBMET01146 | |
| 0.004 | 0.885 | 0.052 | Fatty acid synthase inhibitor | 0.052 0.048 DBMET01146 | DBMET01146 | |
| 0.003 | 0.885 | 0.297 | Pyruvate kinase inhibitor | 0.201 0.08 DBMET01126 0.297 0.048 DBMET01146 | DBMET01146 | |
| 0.013 | 0.896 | 0.349 | Gastrin inhibitor | 0.226 0.11 DBMET03248 0.22 0.119 DBMET01126 0.349 0.011 DBMET01146 | DBMET01146 | |
| 0.013 | 0.897 | 0.182 | DNA polymerase I inhibitor | 0.182 0.034 DBMET01146 | DBMET01146 | |
| 0.004 | 0.89 | 0.039 | Estrogen-related receptor beta antagonist | 0.039 0.012 DBMET03248 0.03 0.029 DBMET01102 | DBMET03248 | |
| 0.008 | 0.896 | 0.058 | Factor III inhibitor | 0.049 0.037 DBMET03248 0.058 0.02 DBMET01146 | DBMET01146 | |
| 0.004 | 0.892 | 0.035 | Caspase 6 inhibitor | 0.035 0.013 DBMET00023 | DBMET00023 | |
| 0.003 | 0.894 | 0.13 | MAP kinase kinase 1 inhibitor | 0.13 0.026 DBMET03248 0.112 0.043 DBMET01146 | DBMET03248 | |
| 0.009 | 0.902 | 0.484 | Vasodilator, peripheral | 0.215 0.159 DBMET03248 0.207 0.168 DBMET01126 0.484 0.031 DBMET01146 | DBMET01146 | |
| 0.002 | 0.897 | 0.083 | Peroxisome proliferator-activated receptor gamma antagonist | 0.083 0.03 DBMET01146 | DBMET01146 | |
| 0.01 | 0.909 | 0.19 | Histone acetyltransferase inhibitor | 0.169 0.114 DBMET00023 0.19 0.084 DBMET03248 | DBMET03248 | |
| 0.008 | 0.907 | 0.273 | ATPase inhibitor | 0.177 0.062 DBMET00023 0.169 0.072 DBMET03248 0.273 0.009 DBMET01126 0.241 0.016 DBMET01146 | DBMET01126 | |
| 0.003 | 0.907 | 0.112 | Beta amyloid protein antagonist | 0.112 0.076 DBMET01146 | DBMET01146 | |
| 0.001 | 0.908 | 0.049 | Liver X receptor alpha agonist | 0.049 0.02 DBMET01146 | DBMET01146 | |
| 0.017 | 0.924 | 0.144 | Transcription factor NF kappa B stimulant | 0.082 0.066 DBMET01126 0.144 0.017 DBMET01146 | DBMET01146 | |
| 0.008 | 0.919 | 0.272 | Chymotrypsin inhibitor | 0.272 0.005 DBMET00023 0.102 0.035 DBMET03248 0.079 0.056 DBMET01100 0.116 0.027 DBMET01126 | DBMET00023 | |
| 0.007 | 0.92 | 0.247 | DNA methylase inhibitor | 0.247 0.05 DBMET01146 | DBMET01146 | |
| 0.007 | 0.923 | 0.05 | Glutamate (mGluR8) antagonist | 0.05 0.008 DBMET01146 | DBMET01146 | |
| 0.002 | 0.919 | 0.11 | MAP kinase kinase inhibitor | 0.1 0.095 DBMET03248 0.11 0.084 DBMET01146 | DBMET01146 | |
| 0 | 0.917 | 0.011 | Immunosuppressant Cyclosporine-like | 0.011 0.008 DBMET01126 | DBMET01126 | |
| 0.004 | 0.922 | 0.991 | Butyrylcholinesterase inhibitor | 0.991 0.002 DBMET01150 | DBMET01150 | |
| 0.002 | 0.924 | 0.082 | Antineoplastic antibiotic | 0.078 0.058 DBMET01126 0.082 0.056 DBMET01146 | DBMET01146 | |
| 0.002 | 0.924 | 0.085 | Estrogen agonist | 0.085 0.021 DBMET03248 | DBMET03248 | |
| 0.002 | 0.924 | 0.095 | Inducible nitric-oxide synthase inhibitor | 0.095 0.041 DBMET01146 | DBMET01146 | |
| 0.003 | 0.926 | 0.141 | Mediator release inhibitor | 0.141 0.033 DBMET01146 | DBMET01146 | |
| 0.003 | 0.928 | 0.235 | Transcription factor STAT3 inhibitor | 0.235 0.096 DBMET01126 0.217 0.114 DBMET01146 | DBMET01126 | |
| 0.005 | 0.932 | 0.232 | Cell wall synthesis inhibitor | 0.135 0.08 DBMET03248 0.137 0.078 DBMET01126 0.232 0.02 DBMET01146 | DBMET01146 | |
| 0.004 | 0.931 | 0.17 | Topoisomerase II alpha inhibitor | 0.17 0.02 DBMET00023 0.142 0.025 DBMET03248 | DBMET00023 | |
| 0.003 | 0.93 | 0.231 | 12-Lipoxygenase inhibitor | 0.19 0.162 DBMET01126 0.231 0.121 DBMET01146 | DBMET01146 | |
| 0.003 | 0.931 | 0.294 | Insulin sensitizer | 0.157 0.123 DBMET03248 0.158 0.123 DBMET01126 0.294 0.017 DBMET01146 | DBMET01146 | |
| 0.005 | 0.935 | 0.266 | DNA methyltransferase I inhibitor | 0.139 0.117 DBMET01126 0.266 0.04 DBMET01146 | DBMET01146 | |
| 0.01 | 0.943 | 0.052 | Adenine nucleotide translocase inhibitor | 0.052 0.051 DBMET01100 | DBMET01100 | |
| 0.003 | 0.936 | 0.099 | Nitric-oxide synthase inhibitor | 0.099 0.061 DBMET01126 0.09 0.078 DBMET01146 | DBMET01126 | |
| 0.004 | 0.944 | 0.203 | Transcription factor STAT inhibitor | 0.203 0.134 DBMET01126 0.194 0.148 DBMET01146 | DBMET01126 | |
| 0.003 | 0.945 | 0.354 | Cyclin-dependent kinase 5 inhibitor | 0.201 0.022 DBMET00023 0.354 0.006 DBMET03248 | DBMET03248 | |
| 0.004 | 0.95 | 0.925 | Acetylcholinesterase inhibitor | 0.925 0.002 DBMET01150 | DBMET01150 | |
| 0.003 | 0.953 | 0.272 | 15-Lipoxygenase inhibitor | 0.272 0.148 DBMET01146 | DBMET01146 | |
| 0.003 | 0.956 | 0.238 | Non-steroidal antiinflammatory agent | 0.177 0.09 DBMET01126 0.238 0.048 DBMET01146 | DBMET01146 | |
| 0.005 | 0.959 | 0.302 | Angiogenesis inhibitor | 0.219 0.149 DBMET00021 0.302 0.091 DBMET01126 0.266 0.112 DBMET01146 | DBMET01126 | |
| 0.002 | 0.96 | 0.109 | Gastric antisecretory | 0.109 0.055 DBMET01146 | DBMET01146 | |
| 0.032 | 0.99 | 0.329 | Peptidyltransferase inhibitor | 0.278 0.034 DBMET03248 0.183 0.123 DBMET01100 0.215 0.081 DBMET01126 0.329 0.016 DBMET01146 | DBMET01146 | |
| 0.002 | 0.961 | 0.179 | Diuretic | 0.179 0.054 DBMET01146 | DBMET01146 | |
| 0 | 0.96 | 0.012 | Calcineurin inhibitor | 0.012 0.007 DBMET01146 | DBMET01146 | |
| 0.002 | 0.963 | 0.253 | Lipoxygenase inhibitor | 0.253 0.098 DBMET01146 | DBMET01146 | |
| 0.029 | 0.99 | 0.172 | ErbB-1 antagonist | 0.172 0.13 DBMET01126 0.166 0.141 DBMET01146 | DBMET01126 | |
| 0.004 | 0.966 | 0.133 | Tumour necrosis factor antagonist | 0.133 0.122 DBMET01126 | DBMET01126 | |
| 0.004 | 0.969 | 0.134 | Hemostatic | 0.134 0.09 DBMET03248 0.122 0.11 DBMET01146 | DBMET03248 | |
| 0.003 | 0.97 | 0.171 | Vascular endothelial growth factor 3 antagonist | 0.171 0.054 DBMET01102 | DBMET01102 | |
| 0.01 | 0.979 | 0.061 | Prolactin release inhibitor | 0.061 0.049 DBMET01146 | DBMET01146 | |
| 0.006 | 0.976 | 0.158 | Acetylcholine M3 receptor agonist | 0.158 0.016 DBMET01077 | DBMET01077 | |
| 0.002 | 0.972 | 0.082 | Leukotriene A4 hydrolase inhibitor | 0.082 0.008 DBMET01100 | DBMET01100 | |
| 0.004 | 0.975 | 0.888 | Cholinergic | 0.888 0.003 DBMET01150 | DBMET01150 | |
| 0.003 | 0.975 | 0.132 | Antipruritic | 0.132 0.118 DBMET01146 | DBMET01146 | |
| 0.002 | 0.975 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.034 0.007 DBMET00024 | DBMET00024 | |
| 0.004 | 0.979 | 0.144 | Estrogen antagonist | 0.144 0.026 DBMET01146 | DBMET01146 | |
| 0.003 | 0.978 | 0.118 | Plasmin inhibitor | 0.118 0.014 DBMET00023 0.088 0.02 DBMET01126 | DBMET00023 | |
| 0.009 | 0.985 | 0.395 | 3C-Like protease (SARS coronavirus) inhibitor | 0.395 0.003 DBMET00023 0.089 0.047 DBMET00792 0.324 0.003 DBMET01126 | DBMET00023 | |
| 0.015 | 0.991 | 0.182 | Lipocortins synthesis antagonist | 0.182 0.069 DBMET01146 | DBMET01146 | |
| 0.006 | 0.983 | 0.061 | Integrin alpha1beta1 antagonist | 0.061 0.004 DBMET01146 | DBMET01146 | |
| 0.018 | 0.995 | 0.331 | Interleukin 2 agonist | 0.217 0.161 DBMET03248 0.206 0.178 DBMET01100 0.331 0.055 DBMET01146 | DBMET01146 | |
| 0.007 | 0.985 | 0.056 | Cathepsin E inhibitor | 0.056 0.047 DBMET01146 | DBMET01146 | |
| 0.006 | 0.984 | 0.302 | Hepatoprotectant | 0.148 0.112 DBMET01100 0.164 0.096 DBMET01126 0.302 0.029 DBMET01146 | DBMET01146 | |
| 0.012 | 0.991 | 0.09 | Folate antagonist | 0.09 0.086 DBMET01146 | DBMET01146 | |
| 0.003 | 0.985 | 0.38 | Antibacterial | 0.219 0.208 DBMET00023 0.235 0.191 DBMET03248 0.375 0.088 DBMET01126 0.38 0.086 DBMET01146 | DBMET01146 | |
| 0.005 | 0.988 | 0.033 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.027 DBMET01146 | DBMET01146 | |
| 0.012 | 0.995 | 0.358 | Factor V inhibitor | 0.358 0.001 DBMET00023 0.185 0.007 DBMET00792 0.112 0.048 DBMET01100 0.332 0.001 DBMET01126 | DBMET00023 | |
| 0.001 | 0.986 | 0.024 | Integrin beta3 antagonist | 0.024 0.011 DBMET01146 | DBMET01146 | |
| 0.01 | 0.996 | 0.336 | Growth hormone agonist | 0.137 0.099 DBMET01100 0.336 0.025 DBMET01146 | DBMET01146 | |
| 0.002 | 0.987 | 0.045 | HMG CoA reductase inhibitor | 0.045 0.01 DBMET01146 | DBMET01146 | |
| 0.008 | 0.994 | 0.086 | Ca(v)3.1 blocker | 0.086 0.044 DBMET01126 | DBMET01126 | |
| 0.009 | 0.995 | 0.339 | Sodium/bile acid cotransporter inhibitor | 0.33 0.054 DBMET01100 0.339 0.047 DBMET01146 | DBMET01146 | |
| 0.003 | 0.99 | 0.117 | Aminoacyl-tRNA synthetase inhibitor | 0.117 0.032 DBMET03248 0.08 0.078 DBMET01146 | DBMET03248 | |
| 0.002 | 0.989 | 0.243 | Bruton tyrosine kinase inhibitor | 0.243 0.005 DBMET01126 0.133 0.009 DBMET01146 | DBMET01126 | |
| 0.01 | 0.997 | 0.134 | Papain-like protease (SARS coronavirus) inhibitor | 0.134 0.053 DBMET01126 0.124 0.072 DBMET01146 | DBMET01126 | |
| 0.008 | 0.995 | 0.389 | ABCA1 expression enhancer | 0.191 0.01 DBMET00023 0.091 0.064 DBMET03248 0.102 0.047 DBMET00792 0.128 0.026 DBMET01126 0.389 0.004 DBMET01146 | DBMET01146 | |
| 0.003 | 0.99 | 0.116 | Protein 50S ribosomal subunit inhibitor | 0.095 0.014 DBMET00023 0.116 0.01 DBMET01126 | DBMET01126 | |
| 0.003 | 0.991 | 0.06 | Human rhinovirus A protease inhibitor | 0.06 0.035 DBMET00023 | DBMET00023 | |
| 0.002 | 0.991 | 0.061 | Neuraminidase inhibitor | 0.061 0.042 DBMET03248 0.057 0.047 DBMET01146 | DBMET03248 | |
| 0.003 | 0.993 | 0.104 | Topoisomerase II inhibitor | 0.104 0.082 DBMET03248 | DBMET03248 | |
| 0.003 | 0.992 | 0.099 | ATPase (Vacuolar H+) inhibitor | 0.099 0.041 DBMET01146 | DBMET01146 | |
| 0.001 | 0.991 | 0.191 | ErbB-4 antagonist | 0.149 0.021 DBMET01126 0.191 0.014 DBMET01146 | DBMET01146 | |
| 0.004 | 0.994 | 0.757 | Antiinflammatory | 0.353 0.17 DBMET01126 0.757 0.021 DBMET01146 | DBMET01146 | |
| 0.002 | 0.991 | 0.276 | Calpain 1 inhibitor | 0.276 0.002 DBMET00023 0.033 0.025 DBMET00792 0.2 0.003 DBMET01126 | DBMET00023 | |
| 0.005 | 0.995 | 0.085 | Hematopoietic | 0.085 0.06 DBMET01100 | DBMET01100 | |
| 0.003 | 0.994 | 0.155 | Chelator | 0.155 0.034 DBMET01146 | DBMET01146 | |
| 0.002 | 0.993 | 0.099 | Aldose reductase inhibitor | 0.099 0.018 DBMET01146 | DBMET01146 | |
| 0.002 | 0.993 | 0.077 | CDK4/cyclin D inhibitor | 0.077 0.023 DBMET01126 | DBMET01126 | |
| 0.006 | 0.998 | 0.585 | NOS3 expression enhancer | 0.205 0.039 DBMET01126 0.585 0.004 DBMET01146 | DBMET01146 | |
| 0.004 | 0.995 | 0.238 | Insulin secretagoues | 0.238 0.022 DBMET01146 | DBMET01146 | |
| 0.005 | 0.996 | 0.87 | Caspase 3 stimulant | 0.252 0.11 DBMET00023 0.87 0.003 DBMET01126 0.378 0.051 DBMET01146 | DBMET01126 | |
| 0.004 | 0.995 | 0.186 | ErbB-3 antagonist | 0.128 0.026 DBMET01126 0.186 0.011 DBMET01146 | DBMET01146 | |
| 0.004 | 0.995 | 0.238 | Vasodilator | 0.238 0.076 DBMET01126 0.23 0.082 DBMET01146 | DBMET01126 | |
| 0.002 | 0.993 | 0.137 | CDK4/cyclin D1 inhibitor | 0.137 0.008 DBMET01126 | DBMET01126 | |
| 0.003 | 0.994 | 0.445 | MAP3K7 inhibitor | 0.065 0.063 DBMET01126 0.445 0.003 DBMET01146 | DBMET01146 | |
| 0.002 | 0.994 | 0.063 | Protein kinase C theta inhibitor | 0.063 0.031 DBMET03248 | DBMET03248 | |
| 0.003 | 0.995 | 0.281 | Angiogenesis stimulant | 0.206 0.091 DBMET01100 0.281 0.056 DBMET01146 | DBMET01146 | |
| 0.003 | 0.995 | 0.089 | Estrogen receptor beta antagonist | 0.089 0.085 DBMET01146 | DBMET01146 | |
| 0.004 | 0.996 | 0.083 | DNA helicase inhibitor | 0.083 0.01 DBMET01146 | DBMET01146 | |
| 0.001 | 0.993 | 0.038 | Leukotriene B4 receptor 2 antagonist | 0.038 0.005 DBMET01146 | DBMET01146 | |
| 0.003 | 0.995 | 0.098 | Thrombin inhibitor | 0.098 0.027 DBMET00023 | DBMET00023 | |
| 0.003 | 0.996 | 0.297 | Cyclophilin D inhibitor | 0.297 0.166 DBMET01146 | DBMET01146 | |
| 0.003 | 0.996 | 0.393 | Antioxidant | 0.256 0.08 DBMET01126 0.393 0.036 DBMET01146 | DBMET01146 | |
| 0.003 | 0.996 | 0.478 | Platelet adhesion inhibitor | 0.206 0.068 DBMET03248 0.478 0.006 DBMET01126 0.325 0.026 DBMET01146 | DBMET01126 | |
| 0.003 | 0.996 | 0.19 | Thrombolytic | 0.135 0.094 DBMET01100 0.19 0.057 DBMET01146 | DBMET01146 | |
| 0.003 | 0.996 | 0.349 | Hypolipemic | 0.349 0.035 DBMET01146 | DBMET01146 | |
| 0.003 | 0.996 | 0.113 | Protease inhibitor | 0.113 0.054 DBMET00023 0.096 0.069 DBMET01126 | DBMET00023 | |
| 0.003 | 0.996 | 0.479 | EphB2 antagonist | 0.479 0.008 DBMET01146 | DBMET01146 | |
| 0.002 | 0.996 | 0.121 | Factor XII inhibitor | 0.121 0.023 DBMET00023 0.078 0.07 DBMET01126 | DBMET00023 | |
| 0.003 | 0.996 | 0.43 | Hypoglycemic | 0.43 0.023 DBMET03248 0.198 0.115 DBMET01126 0.388 0.03 DBMET01146 | DBMET03248 | |
| 0.002 | 0.995 | 0.193 | VCAM-1 antagonist | 0.193 0.004 DBMET01146 | DBMET01146 | |
| 0.002 | 0.995 | 0.193 | VCAM antagonist | 0.193 0.004 DBMET01146 | DBMET01146 | |
| 0.003 | 0.996 | 0.33 | Free radical scavenger | 0.221 0.082 DBMET01126 0.33 0.044 DBMET01146 | DBMET01146 | |
| 0.002 | 0.996 | 0.228 | Cathepsin B inhibitor | 0.228 0.004 DBMET00023 0.188 0.005 DBMET01126 | DBMET00023 | |
| 0.002 | 0.995 | 0.434 | Prostaglandin EP2 antagonist | 0.434 0.004 DBMET01146 | DBMET01146 | |
| 0.001 | 0.995 | 0.011 | Glucocorticoid agonist | 0.011 0.01 DBMET03248 | DBMET03248 | |
| 0.002 | 0.996 | 0.094 | Lipase inhibitor | 0.094 0.031 DBMET01126 | DBMET01126 | |
| 0.002 | 0.996 | 0.089 | Prostaglandin F2 alpha antagonist | 0.089 0.016 DBMET01146 | DBMET01146 | |
| 0.002 | 0.996 | 0.265 | Protein-tyrosine phosphatase 1B inhibitor | 0.265 0.014 DBMET01146 | DBMET01146 | |
| 0.001 | 0.995 | 0.047 | GP IIb/IIIa receptor antagonist | 0.047 0.035 DBMET01146 | DBMET01146 | |
| 0.003 | 0.997 | 0.372 | Apoptosis antagonist | 0.316 0.075 DBMET01126 0.372 0.047 DBMET01146 | DBMET01146 | |
| 0.003 | 0.997 | 0.111 | Caspase 9 inhibitor | 0.107 0.012 DBMET00023 0.111 0.011 DBMET01126 0.063 0.041 DBMET01146 | DBMET01126 | |
| 0.002 | 0.996 | 0.061 | Trypsin inhibitor | 0.061 0.045 DBMET01126 | DBMET01126 | |
| 0.001 | 0.995 | 0.06 | Prostaglandin D2 agonist | 0.06 0.005 DBMET01146 | DBMET01146 | |
| 0.002 | 0.996 | 0.454 | Platelet antagonist | 0.454 0.019 DBMET01146 | DBMET01146 | |
| 0 | 0.995 | 0.037 | 3C-Like protease (MERS coronavirus) inhibitor | 0.037 0.002 DBMET00023 0.036 0.002 DBMET01126 | DBMET00023 | |
| 0.002 | 0.996 | 0.493 | Nitric oxide antagonist | 0.493 0.016 DBMET01126 0.42 0.023 DBMET01146 | DBMET01126 | |
| 0.002 | 0.996 | 0.061 | Sirtuin 1 inhibitor | 0.061 0.058 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.074 | Retinoic acid gamma receptor agonist | 0.074 0.003 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.104 | Fibroblast growth factor 4 antagonist | 0.104 0.008 DBMET01126 0.074 0.023 DBMET01146 | DBMET01126 | |
| 0.002 | 0.997 | 0.234 | Tumour necrosis factor alpha release inhibitor | 0.234 0.083 DBMET01146 | DBMET01146 | |
| 0.002 | 0.997 | 0.373 | Interleukin 6 antagonist | 0.373 0.009 DBMET01146 | DBMET01146 | |
| 0.002 | 0.996 | 0.122 | HIV-1 integrase inhibitor | 0.122 0.014 DBMET01146 | DBMET01146 | |
| 0.002 | 0.996 | 0.112 | Cell adhesion molecule inhibitor | 0.112 0.027 DBMET01146 | DBMET01146 | |
| 0.002 | 0.997 | 0.041 | HCV polyprotein inhibitor | 0.041 0.011 DBMET01146 | DBMET01146 | |
| 0.002 | 0.997 | 0.323 | Protein-tyrosine phosphatase inhibitor | 0.323 0.015 DBMET01146 | DBMET01146 | |
| 0.002 | 0.996 | 0.134 | CDC25A inhibitor | 0.134 0.015 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.025 | Cathepsin K inhibitor | 0.025 0.021 DBMET00023 | DBMET00023 | |
| 0.002 | 0.997 | 0.229 | Interleukin 1 antagonist | 0.229 0.023 DBMET01146 | DBMET01146 | |
| 0 | 0.995 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 DBMET01126 | DBMET01126 | |
| 0.002 | 0.997 | 0.295 | Interleukin antagonist | 0.295 0.049 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.104 | Retinoic acid beta receptor agonist | 0.104 0.003 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.146 | Retinoic acid alpha receptor agonist | 0.146 0.003 DBMET01146 | DBMET01146 | |
| 0.002 | 0.997 | 0.093 | Falcipain inhibitor | 0.093 0.06 DBMET01126 | DBMET01126 | |
| 0.001 | 0.996 | 0.083 | Integrin antagonist | 0.083 0.019 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.033 | Integrin beta5 antagonist | 0.033 0.008 DBMET01146 | DBMET01146 | |
| 0.002 | 0.997 | 0.096 | Elastase 1 inhibitor | 0.096 0.023 DBMET01126 | DBMET01126 | |
| 0.002 | 0.997 | 0.13 | Lipid peroxidase inhibitor | 0.13 0.083 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.293 | Retinoid X beta receptor agonist | 0.293 0.002 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.185 | Retinoid X gamma receptor agonist | 0.185 0.002 DBMET01146 | DBMET01146 | |
| 0.002 | 0.997 | 0.239 | Cell adhesion inhibitor | 0.239 0.016 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.02 | Prostaglandin EP1 antagonist | 0.02 0.014 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.105 | Selectin antagonist | 0.105 0.026 DBMET01146 | DBMET01146 | |
| 0.002 | 0.998 | 0.158 | Interleukin 4 antagonist | 0.122 0.083 DBMET01126 0.158 0.043 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.034 | Nicotinic acid receptor 2 agonist | 0.034 0.028 DBMET03248 | DBMET03248 | |
| 0.001 | 0.996 | 0.026 | Vitronectin receptor antagonist | 0.026 0.012 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.03 | Cyclophilin A inhibitor | 0.03 0.022 DBMET01100 | DBMET01100 | |
| 0.001 | 0.997 | 0.128 | Retinoic acid receptor agonist | 0.128 0.004 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.111 | HIV-1 integrase (3'-Processing) inhibitor | 0.111 0.022 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.106 | Retinoid X gamma receptor antagonist | 0.106 0.001 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.097 | Prostaglandin E2 antagonist | 0.097 0.015 DBMET01146 | DBMET01146 | |
| 0.001 | 0.996 | 0.033 | Prostacyclin agonist | 0.033 0.005 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.088 | CDC25B inhibitor | 0.076 0.031 DBMET01126 0.088 0.022 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.133 | HIV-1 integrase (Strand Transfer) inhibitor | 0.068 0.037 DBMET01126 0.133 0.014 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.213 | Prostaglandin antagonist | 0.213 0.006 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.173 | Peroxisome proliferator-activated receptor gamma agonist | 0.173 0.009 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.095 | Transcription factor AP-1 inhibitor | 0.095 0.014 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.075 | Prostacyclin antagonist | 0.075 0.006 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.05 | VLA-4 antagonist | 0.05 0.013 DBMET01146 | DBMET01146 | |
| 0.001 | 0.998 | 0.183 | Uric acid excretion stimulant | 0.116 0.04 DBMET03248 0.09 0.065 DBMET01126 0.183 0.016 DBMET01146 | DBMET01146 | |
| 0.002 | 0.998 | 0.218 | Interleukin 1b antagonist | 0.218 0.016 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.109 | Leukotriene B4 receptor 1 antagonist | 0.109 0.004 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.058 | Prostaglandin D2 antagonist | 0.058 0.006 DBMET01146 | DBMET01146 | |
| 0 | 0.997 | 0.086 | Retinoic acid alpha receptor antagonist | 0.086 0.003 DBMET01146 | DBMET01146 | |
| 0 | 0.997 | 0.035 | Retinoic acid receptor gamma antagonist | 0.035 0.004 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.036 | Peroxisome proliferator-activated receptor delta antagonist | 0.036 0.019 DBMET01146 | DBMET01146 | |
| 0.001 | 0.998 | 0.091 | Leukotriene synthesis inhibitor | 0.091 0.031 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.026 | NMDA 2D receptor antagonist | 0.026 0.02 DBMET01146 | DBMET01146 | |
| 0.001 | 0.998 | 0.163 | Amyloid beta precursor protein antagonist | 0.163 0.087 DBMET01126 | DBMET01126 | |
| 0 | 0.997 | 0.04 | Retinoic acid beta receptor antagonist | 0.04 0.004 DBMET01146 | DBMET01146 | |
| 0.001 | 0.998 | 0.06 | Plasminogen activator inhibitor antagonist | 0.06 0.024 DBMET01146 | DBMET01146 | |
| 0 | 0.997 | 0.082 | Retinoic acid receptor antagonist | 0.082 0.003 DBMET01146 | DBMET01146 | |
| 0.001 | 0.997 | 0.161 | Prostaglandin EP3 antagonist | 0.161 0.004 DBMET01146 | DBMET01146 | |
| 0 | 0.997 | 0.024 | Free fatty acid receptor 1 agonist | 0.024 0.008 DBMET01146 | DBMET01146 | |
| 0.001 | 0.998 | 0.096 | 5-Lipoxygenase inhibitor | 0.096 0.067 DBMET01146 | DBMET01146 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |